<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5876930 - Detecting polynucleotide in sample using oligonucleotide probe containing ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_4ff636b3d23669b7103f3b3a3a18b4cd/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_4ff636b3d23669b7103f3b3a3a18b4cd__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized"><meta name="DC.contributor" content="Kenneth J. Livak" scheme="inventor"><meta name="DC.contributor" content="Susan J. A. Flood" scheme="inventor"><meta name="DC.contributor" content="Jeffrey Marmaro" scheme="inventor"><meta name="DC.contributor" content="Khairuzzaman Bashar Mullah" scheme="inventor"><meta name="DC.contributor" content="Perkin-Elmer Corporation" scheme="assignee"><meta name="DC.date" content="1995-11-15" scheme="dateSubmitted"><meta name="DC.description" content="A hybridization assay is provided which uses an oligonucleotide probe which includes a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of the reporter molecule. The oligonucleotide probe is constructed such that the probe exists in at least one single-stranded conformation when unhybridized where the quencher molecule is near enough to the reporter molecule to quench the fluorescence of the reporter molecule. The oligonucleotide probe also exists in at least one conformation when hybridized to a target polynucleotide where the quencher molecule is not positioned close enough to the reporter molecule to quench the fluorescence of the reporter molecule. By adopting these hybridized and unhybridized conformations, the reporter molecule and quencher molecule on the probe exhibits different fluorescence signal intensities when the probe is hybridized and unhybridized. As a result, it is possible to determine whether the probe is hybridized or unhybridized based on a change in the fluorescence intensity of the reporter molecule, the quencher molecule, or a combination thereof. In addition, because the probe can be designed such that the quencher molecule quenches the reporter molecule when the probe is not hybridized, the probe can be designed such that the reporter molecule exhibits limited fluorescence until the probe is either hybridized or digested."><meta name="DC.date" content="1999-3-2" scheme="issued"><meta name="DC.relation" content="EP:0229943" scheme="references"><meta name="DC.relation" content="EP:0601889:A2" scheme="references"><meta name="DC.relation" content="JP:H05123195" scheme="references"><meta name="DC.relation" content="US:4220450" scheme="references"><meta name="DC.relation" content="US:5210015" scheme="references"><meta name="DC.relation" content="US:5332659" scheme="references"><meta name="DC.relation" content="US:5491063" scheme="references"><meta name="DC.relation" content="WO:1990003446:A1" scheme="references"><meta name="DC.relation" content="WO:1992002638:A1" scheme="references"><meta name="DC.relation" content="WO:1993013224:A1" scheme="references"><meta name="citation_reference" content="Cardullo et al., &quot;Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer&quot;, Proc. Natl. Acad. Sci., 85: 8790-8794 (1988)."><meta name="citation_reference" content="Cardullo et al., Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer , Proc. Natl. Acad. Sci., 85: 8790 8794 (1988)."><meta name="citation_reference" content="Clegg et al., &quot;Observing the helical geometry of double-stranded DNA in solution by fluorescene resonance energy transfer&quot;, Proc. Natl. Acad. Sci., 90: 2994-2998 (1993)."><meta name="citation_reference" content="Clegg et al., Observing the helical geometry of double stranded DNA in solution by fluorescene resonance energy transfer , Proc. Natl. Acad. Sci., 90: 2994 2998 (1993)."><meta name="citation_reference" content="Clegg, &quot;Fluorescence resonance energy transfer and nucleic acids,&quot; Methods of Enzymology, 211: 353-389 (1992)."><meta name="citation_reference" content="Clegg, Fluorescence resonance energy transfer and nucleic acids, Methods of Enzymology, 211: 353 389 (1992)."><meta name="citation_reference" content="Heller et al., &quot;Fluorescent energy transfer oligonucleotide probes&quot;, Abstract 248, Fed. Proc., 46: 1968 (1987)."><meta name="citation_reference" content="Heller et al., Fluorescent energy transfer oligonucleotide probes , Abstract 248, Fed. Proc., 46: 1968 (1987)."><meta name="citation_reference" content="Higuchi et al., &quot;Kinetic PCR analysis: real-time monitoring of DNA amplification reactions,&quot; Biotechnology, 11:1026-1030 (1993)."><meta name="citation_reference" content="Higuchi et al., &quot;Simultaneous amplification and detection of specific DNA sequences&quot;, Biotechnology, 10:413-417 (1992)."><meta name="citation_reference" content="Higuchi et al., Kinetic PCR analysis: real time monitoring of DNA amplification reactions, Biotechnology, 11:1026 1030 (1993)."><meta name="citation_reference" content="Higuchi et al., Simultaneous amplification and detection of specific DNA sequences , Biotechnology, 10:413 417 (1992)."><meta name="citation_reference" content="Holland et al., Detection of specific polymerase chain reaction product by utilizing the 5 3 exonuclease activity of the Thermus acquaticus DNA polymerase , Proc. Natl. Acad. Sci., 88: 7276 7280 (1991)."><meta name="citation_reference" content="Holland et al., Detection of specific polymerase chain reaction product by utilizing the 5&#39;â†’3&#39; exonuclease activity of the Thermus acquaticus DNA polymerase , Proc. Natl. Acad. Sci., 88: 7276-7280 (1991)."><meta name="citation_reference" content="Jean Louis Mergny et al., Fluorescence Energy Transfer as a Probe for Nucleic Acid Structures and Sequences, Nucleic Acids Research, 1994, vol. 22, No. 6."><meta name="citation_reference" content="Jean-Louis Mergny et al., &quot;Fluorescence Energy Transfer as a Probe for Nucleic Acid Structures and Sequences,&quot; Nucleic Acids Research, 1994, vol. 22, No. 6."><meta name="citation_reference" content="K. J. Livak et al., Oligonucleotides with Fluoresc. Dyes at Opp. Ends Provide a Quenched Probe System Useful for Detecting PCR Prod. and Nucleic Acid Hybrid., PCR Methods and Applications, pp. 357 362, 1994."><meta name="citation_reference" content="K. J. Livak et al., Oligonucleotides with Fluoresc. Dyes at Opp. Ends Provide a Quenched Probe System Useful for Detecting PCR Prod. and Nucleic Acid Hybrid., PCR Methods and Applications, pp. 357-362, 1994."><meta name="citation_reference" content="Lee et al., &quot;Allelic discrimination by nick-translation PCR with fluorogenic probes,&quot; Nucleic Acids Research, 21: 3761-3766 (1993)."><meta name="citation_reference" content="Lee et al., Allelic discrimination by nick translation PCR with fluorogenic probes, Nucleic Acids Research, 21: 3761 3766 (1993)."><meta name="citation_reference" content="Ozaki et al., &quot;The estimation of distances between specific backbone-labeled sites in DNA using fluorescence resonance energy transfer,&quot; Nucleic Acids Research, 20: 5205-5214 (1992)."><meta name="citation_reference" content="Ozaki et al., The estimation of distances between specific backbone labeled sites in DNA using fluorescence resonance energy transfer, Nucleic Acids Research, 20: 5205 5214 (1992)."><meta name="citation_reference" content="Parkhurst, et al. &quot;Kinetic Studies by Fluorescence Resonance Energy Transfer Employing a Double-Labeled Oligonucleotide: Hybridization to the Oligonucleotide Complement and to Single-Stranded DNA&quot;, Biochemistry, 34, 285-292 (1995)."><meta name="citation_reference" content="Parkhurst, et al. Kinetic Studies by Fluorescence Resonance Energy Transfer Employing a Double Labeled Oligonucleotide: Hybridization to the Oligonucleotide Complement and to Single Stranded DNA , Biochemistry, 34, 285 292 (1995)."><meta name="citation_reference" content="Roche Inventor Disclosure (disclosed to Applied Biosystems prior to Nov. 1994)."><meta name="citation_reference" content="S. Tyagi et al., Molecular Beacons: Probes that Fluoresce upon Hybrodization, Dept. of Molecular Genetics, Public Health Research Institute, New York, N. Y., 1994."><meta name="citation_reference" content="Stryer et al., &quot;Energy transfer: a spectroscopic ruler&quot;, Proc. Natl. Acad. Sci., 58: 719-726 (1967)."><meta name="citation_reference" content="Stryer et al., Energy transfer: a spectroscopic ruler , Proc. Natl. Acad. Sci., 58: 719 726 (1967)."><meta name="citation_reference" content="Wu et al., &quot;Resonance energy transfer: methods and applications,&quot; Anal. Biochem., 218: 1-13 (1994)."><meta name="citation_reference" content="Wu et al., Resonance energy transfer: methods and applications, Anal. Biochem., 218: 1 13 (1994)."><meta name="citation_reference" content="Z. Guo et al., &quot;Direct Fluoresc. Analysis of Genetic Polymorph. by Hybrid. with Oligonucleptide Arrays on Glass Suports&quot;, Nucleic Acids Research, 1994, vol. 22, No. 24."><meta name="citation_reference" content="Z. Guo et al., Direct Fluoresc. Analysis of Genetic Polymorph. by Hybrid. with Oligonucleptide Arrays on Glass Suports , Nucleic Acids Research, 1994, vol. 22, No. 24."><meta name="citation_patent_number" content="US:5876930"><meta name="citation_patent_application_number" content="US:08/558,303"><link rel="canonical" href="http://www.google.com/patents/US5876930"/><meta property="og:url" content="http://www.google.com/patents/US5876930"/><meta name="title" content="Patent US5876930 - Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized"/><meta name="description" content="A hybridization assay is provided which uses an oligonucleotide probe which includes a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of the reporter molecule. The oligonucleotide probe is constructed such that the probe exists in at least one single-stranded conformation when unhybridized where the quencher molecule is near enough to the reporter molecule to quench the fluorescence of the reporter molecule. The oligonucleotide probe also exists in at least one conformation when hybridized to a target polynucleotide where the quencher molecule is not positioned close enough to the reporter molecule to quench the fluorescence of the reporter molecule. By adopting these hybridized and unhybridized conformations, the reporter molecule and quencher molecule on the probe exhibits different fluorescence signal intensities when the probe is hybridized and unhybridized. As a result, it is possible to determine whether the probe is hybridized or unhybridized based on a change in the fluorescence intensity of the reporter molecule, the quencher molecule, or a combination thereof. In addition, because the probe can be designed such that the quencher molecule quenches the reporter molecule when the probe is not hybridized, the probe can be designed such that the reporter molecule exhibits limited fluorescence until the probe is either hybridized or digested."/><meta property="og:title" content="Patent US5876930 - Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("-VvpU8W2EvWwsAScu4HIBA"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407464522.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("USA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("-VvpU8W2EvWwsAScu4HIBA"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407464522.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("USA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5876930?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5876930"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=5dRJBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5876930&amp;usg=AFQjCNFR9tiDEMru_rpc2SnFj6vG_Q96Ag" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5876930.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5876930.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5876930" style="display:none"><span itemprop="description">A hybridization assay is provided which uses an oligonucleotide probe which includes a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of the reporter molecule. The oligonucleotide probe is constructed such that the probe exists in at least one single-stranded...</span><span itemprop="url">http://www.google.com/patents/US5876930?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5876930 - Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5876930 - Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized" title="Patent US5876930 - Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5876930 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/558,303</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Mar 2, 1999</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Nov 15, 1995</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Nov 16, 1994</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2201756A1">CA2201756A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2201756C">CA2201756C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69519940D1">DE69519940D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69519940T2">DE69519940T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0792374A1">EP0792374A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0792374B1">EP0792374B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0972848A2">EP0972848A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0972848A3">EP0972848A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5538848">US5538848</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5723591">US5723591</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6030787">US6030787</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6258569">US6258569</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1996015270A1">WO1996015270A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08558303, </span><span class="patent-bibdata-value">558303, </span><span class="patent-bibdata-value">US 5876930 A, </span><span class="patent-bibdata-value">US 5876930A, </span><span class="patent-bibdata-value">US-A-5876930, </span><span class="patent-bibdata-value">US5876930 A, </span><span class="patent-bibdata-value">US5876930A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Kenneth+J.+Livak%22">Kenneth J. Livak</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Susan+J.+A.+Flood%22">Susan J. A. Flood</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Jeffrey+Marmaro%22">Jeffrey Marmaro</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Khairuzzaman+Bashar+Mullah%22">Khairuzzaman Bashar Mullah</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Perkin-Elmer+Corporation%22">Perkin-Elmer Corporation</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5876930.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5876930.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5876930.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (10),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (32),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (167),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (20),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (14)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5876930&usg=AFQjCNEHbIeXDw7xrwWWDYmsz7acNiHmog">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5876930&usg=AFQjCNGBYfdjqRR01jM6PGDFtftK6_VTjw">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5876930A%26KC%3DA%26FT%3DD&usg=AFQjCNGHYGY9ECgPvAmTAjfe6n0JCd4zsw">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129700374" lang="EN" load-source="ifi">Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized</invention-title></span><br><span class="patent-number">US 5876930 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37883809" lang="EN" load-source="patent-office"> <div class="abstract">A hybridization assay is provided which uses an oligonucleotide probe which includes a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of the reporter molecule. The oligonucleotide probe is constructed such that the probe exists in at least one single-stranded conformation when unhybridized where the quencher molecule is near enough to the reporter molecule to quench the fluorescence of the reporter molecule. The oligonucleotide probe also exists in at least one conformation when hybridized to a target polynucleotide where the quencher molecule is not positioned close enough to the reporter molecule to quench the fluorescence of the reporter molecule. By adopting these hybridized and unhybridized conformations, the reporter molecule and quencher molecule on the probe exhibits different fluorescence signal intensities when the probe is hybridized and unhybridized. As a result, it is possible to determine whether the probe is hybridized or unhybridized based on a change in the fluorescence intensity of the reporter molecule, the quencher molecule, or a combination thereof. In addition, because the probe can be designed such that the quencher molecule quenches the reporter molecule when the probe is not hybridized, the probe can be designed such that the reporter molecule exhibits limited fluorescence until the probe is either hybridized or digested.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(5)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5876930-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5876930-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5876930-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5876930-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5876930-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5876930-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5876930-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5876930-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5876930-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5876930-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(39)</span></span></div><div class="patent-text"><div mxw-id="PCLM5359945" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A method for detecting a target polynucleotide in a sample comprising:<div class="claim-text">contacting said sample of nucleic acids with an oligonucleotide probe under conditions where said oligonucleotide probe selectively hybridizes to said target polynucleotide, said oligonucleotide probe including a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of said reporter molecule which are attached to said oligonucleotide probe such that said oligonucleotide probe is capable of adopting at least one single-stranded conformation when not hybridized to said target polynucleotide where said quencher molecule quenches the fluorescence of said reporter molecule and is capable of adopting at least one conformation when hybridized to said target polynucleotide where the fluorescence of said reporter molecule is unquenched such that the fluorescence intensity of said reporter molecule when said oligonucleotide probe is hybridized to said target polynucleotide is greater than the fluorescence intensity of said reporter molecule when said oligonucleotide probe is not hybridized to said target polynucleotide and said oligonucleotide probe is not hybridized with itself in the form of a hairpin structure; and</div> <div class="claim-text">monitoring the fluorescence of said reporter molecule fluorescence intensity of said reporter molecule indicating the presence of said under conditions where said oligonucleotide probe does not hybridize with itself to form a hairpin structure in order to detect the hybridization of said target polynucleotide to said oligonucleotide probe.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The method according to claim 1 wherein the fluorescence intensity of said reporter molecule under conditions where said oligonucleotide probe does not hybridize with itself to form a hairpin structure is at least about a factor of 6 greater when said oligonucleotide probe is hybridized to said target polynucleotide than when said oligonucleotide probe is not hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The method according to claim 1 wherein said reporter molecule is separated from said quencher molecule by at least 15 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The method according to claim 1 wherein said reporter molecule is separated from said quencher molecule by between 15 and 60 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. The method according to claim 1 wherein said reporter molecule is separated from said quencher molecule by at least 18 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. The method according to claim 5 wherein said reporter molecule is separated from said quencher molecule by between 18 and 30 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. The method according to claim 1 wherein said reporter molecule is attached to a 3' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The method according to claim 7 wherein said quencher molecule is attached to a 5' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" class="claim">
      <div class="claim-text">9. The method according to claim 1 wherein said reporter molecule is attached to a 5' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. The method according to claim 9 wherein said quencher molecule is attached to a 3' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" class="claim">
      <div class="claim-text">11. The method according to claim 1 wherein said quencher molecule is attached to a 3' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" class="claim">
      <div class="claim-text">12. The method according to claim 1 wherein said quencher molecule is attached to a 5' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" class="claim">
      <div class="claim-text">13. The method according to claim 1 wherein said reporter molecule is a fluorescein dye and said quencher molecule is a rhodamine dye.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" class="claim">
      <div class="claim-text">14. The method according to claim 1 wherein said quencher is fluorescent and the fluorescence intensity of said reporter molecule is greater than the fluorescence intensity of said quencher molecule when said oligonucleotide probe is hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" class="claim">
      <div class="claim-text">15. The method according to claim 14 wherein the fluorescence intensity of said reporter molecule is at least about a factor of 3.5 greater than the fluorescence intensity of said quencher molecule when said probe is hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim"> <div num="16" class="claim">
      <div class="claim-text">16. A method for detecting a target polynucleotide in a sample comprising:<div class="claim-text">contacting said sample of nucleic acids with an oligonucleotide probe under conditions where said oligonucleotide probe selectively hybridizes to said target polynucleotide, said oligonucleotide probe including a fluorescent reporter molecule and a fluorescent quencher molecule capable of quenching the fluorescence of said reporter molecule which are attached to said oligonucleotide probe such that said oligonucleotide probe is capable of adopting at least one single-stranded conformation when not hybridized to said target polynucleotide where said fluorescent quencher molecule quenches the fluorescence of said reporter molecule and is capable of adopting a least one conformation when hybridized to said target polynucleotide where the fluorescence of said reporter molecule is unquenched such that the ratio of the fluorescence intensities of said reporter molecule to said fluorescent quencher molecule when said oligonucleotide sequence is hybridized to said target polynucleotide is greater than the ratio of the fluorescence intensities of said reporter molecule to said fluorescent quencher molecule when said oligonucleotide probe is not hybridized to said target polynucleotide and said oligonucleotide probe is not hybridized with itself in the form of a hairpin structure; and</div> <div class="claim-text">monitoring the ratio between the fluorescence of said reporter molecule and said fluorescent quencher molecule under conditions where said oligonucleotide probe does not hybridize with itself to form a hairpin structure in order to detect the hybridization of said target polynucleotide to said oligonucleotide probe.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" class="claim">
      <div class="claim-text">17. The method according to claim 16 wherein the ratio of the fluorescence intensities of said reporter molecule to said quencher molecule when said oligonucleotide probe is hybridized to said target polynucleotide is at least a factor of 6 greater than the ratio of the fluorescence intensities of said reporter molecule to said quencher molecule when said oligonucleotide probe is not hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim"> <div num="18" class="claim">
      <div class="claim-text">18. A method for detecting a target polynucleotide in a sample comprising:<div class="claim-text">contacting a sample of nucleic acids with an oligonucleotide probe attached to a solid support under conditions favorable for hybridization of said oligonucleotide probe to said target polynucleotide, said oligonucleotide probe including a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of said reporter molecule which are attached to said oligonucleotide probe such that said oligonucleotide probe is capable of adopting at least one single-stranded conformation when not hybridized to said target polynucleotide where said quencher molecule quenches the fluorescence of said reporter molecule and is capable of adopting at least one conformation when hybridized to said target polynucleotide where the fluorescence of said reporter molecule is unquenched such that the fluorescence intensity of said reporter molecule when said oligonucleotide probe is hybridized to said target polynucleotide is greater than the fluorescence intensity of said reporter molecule when said oligonucleotide probe is not hybridized to said target polynucleotide and said oligonucleotide probe is not hybridized with itself in the form of a hairpin structure; and</div> <div class="claim-text">monitoring the fluorescence of said reporter molecule under conditions where said oligonucleotide probe does not hybridize with itself to form a hairpin structure in order to detect the hybridization of said target polynucleotide to said oligonucleotide probe.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" class="claim">
      <div class="claim-text">19. The method according to claim 18 wherein the fluorescence intensity of said reporter molecule under conditions where said oligonucleotide probe does not hybridize with itself to form a hairpin structure is at least about a factor of 6 greater when said oligonucleotide probe is hybridized to said target polynucleotide than when said oligonucleotide probe is not hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" class="claim">
      <div class="claim-text">20. The method according to claim 18 wherein said reporter molecule is separated from said quencher molecule by at least 15 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="21" class="claim">
      <div class="claim-text">21. The method according to claim 20 wherein said reporter molecule is separated from said quencher molecule by between 15 and 60 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="22" class="claim">
      <div class="claim-text">22. The method according to claim 18 wherein said reporter molecule is separated from said quencher molecule by at least 18 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="23" class="claim">
      <div class="claim-text">23. The method according to claim 22 wherein said reporter molecule is separated from said quencher molecule by between 18 and 30 nucleotides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="24" class="claim">
      <div class="claim-text">24. The method according to claim 18 wherein said reporter molecule is attached to a 3' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="25" class="claim">
      <div class="claim-text">25. The method according to claim 24 wherein said quencher molecule is attached to a 5' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="26" class="claim">
      <div class="claim-text">26. The method according to claim 18 wherein said reporter molecule is attached to a 5' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="27" class="claim">
      <div class="claim-text">27. The method according to claim 26 wherein said quencher molecule is attached to a 3' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="28" class="claim">
      <div class="claim-text">28. The method according to claim 18 wherein said quencher molecule is attached to a 3' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="29" class="claim">
      <div class="claim-text">29. The method according to claim 18 wherein said quencher molecule is attached to a 5' terminal nucleotide of said oligonucleotide probe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="30" class="claim">
      <div class="claim-text">30. The method according to claim 18 wherein said reporter molecule is a fluorescein dye and said quencher molecule is a rhodamine dye.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="31" class="claim">
      <div class="claim-text">31. The method according to claim 18 wherein said probe is attached to said solid support by a linker.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="32" class="claim">
      <div class="claim-text">32. The method according to claim 31 wherein said linker separates said probe from said solid support by at least 30 atoms.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="33" class="claim">
      <div class="claim-text">33. The method according to claim 32 wherein said linker separates said probe from said solid support by at least 50 atoms.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="34" class="claim">
      <div class="claim-text">34. The method according to claim 31 wherein said linker is a functionalized polyethylene glycol.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="35" class="claim">
      <div class="claim-text">35. The method according to claim 34 wherein said linker is a polynucleotide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="36" class="claim">
      <div class="claim-text">36. The method according to claim 18 wherein said quencher molecule is fluorescent and the fluorescence intensity of said reporter molecule is greater than the fluorescence intensity of said quencher molecule when said oligonucleotide probe is hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="37" class="claim">
      <div class="claim-text">37. The method according to claim 36 wherein the fluorescence intensity of said reporter molecule is at least about a factor of 3.5 greater than the fluorescence intensity of said quencher molecule when said probe is hybridized to said target polynucleotide.</div>
    </div>
    </div> <div class="claim"> <div num="38" class="claim">
      <div class="claim-text">38. A method for detecting a target polynucleotide in a sample comprising:<div class="claim-text">contacting said sample of nucleic acids with an oligonucleotide probe attached to a solid support under conditions where said oligonucleotide probe selectively hybridizes to said target polynucleotide, said oligonucleotide probe including a fluorescent reporter molecule and a fluorescent quencher molecule capable of quenching the fluorescence of said reporter molecule which are attached to said oligonucleotide probe such that said oligonucleotide probe is capable of adopting at least one single-stranded conformation when not hybridized to said target polynucleotide where said fluorescent quencher molecule quenches the fluorescence of said reporter molecule and is capable of adopting at least one conformation when hybridized to said target polynucleotide where the fluorescence of said reporter molecule is unquenched such that the ratio of the fluorescence intensities of said reporter molecule to said fluorescent quencher molecule when said oligonucleotide sequence is hybridized to said target polynucleotide is greater than the ratio of the fluorescence intensities of said reporter molecule to said fluorescent quencher molecule when said oligonucleotide probe is not hybridized to said target polynucleotide and said oligonucleotide probe is not hybridized with itself in the form of a hairpin structure; and</div> <div class="claim-text">monitoring the ratio between the fluorescence of said reporter molecule and said fluorescent quencher molecule under conditions where said oligonucleotide probe does not hybridize with itself to form a hairpin structure in order to detect the hybridization of said target polynucleotide to said oligonucleotide probe.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="39" class="claim">
      <div class="claim-text">39. The method according to claim 38 wherein the ratio of the fluorescence intensities of said reporter molecule to said quencher molecule when said oligonucleotide sequence is hybridized to said target polynucleotide is at least a factor of 6 greater than the ratio of the fluorescence intensities of said reporter molecule to said quencher molecule when said oligonucleotide sequence is not hybridized to said target polynucleotide.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67251890" lang="EN" load-source="patent-office" class="description">
    <heading>RELATIONSHIP TO COPENDING APPLICATION</heading> <p>This application is a continuation of application Ser. No. 08/340,558, filed Nov. 16, 1994, now U.S. Pat. No. 5,538,848 which is incorporated herein by reference.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>1. Field of the Invention</p>
    <p>The invention relates generally to fluorescent probes which include a fluorescent reporter molecule and a fluorescent quencher molecule. More specifically, the invention relates to fluorescent probes which include a fluorescent reporter molecule and a fluorescent quencher molecule which may be used in hybridization assays and in nucleic acid amplification reactions, especially polymerase chain reactions (PCR).</p>
    <p>2. Description of Related Art</p>
    <p>Fluorescent reporter molecule--quencher molecule pairs have been incorporated onto oligonucleotide probes in order to monitor biological events based on the fluorescent reporter molecule and quencher molecule being separated or brought within a minimum quenching distance of each other. For example, probes have been developed where the intensity of the reporter molecule fluorescence increases due to the separation of the reporter molecule from the quencher molecule. Probes have also been developed which lose their fluorescence because the quencher molecule is brought into proximity with the reporter molecule. These reporter--quencher molecule pair probes have been used to monitor hybridization assays and nucleic acid amplification reactions, especially polymerase chain reactions (PCR), by monitoring either the appearance or disappearance of the fluorescence signal generated by the reporter molecule.</p>
    <p>As used herein, a reporter molecule is a molecule capable of generating a fluorescence signal. A quencher molecule is a molecule capable of absorbing the fluorescence energy of an excited reporter molecule, thereby quenching the fluorescence signal that would otherwise be released from the excited reporter molecule. In order for a quencher molecule to quench an excited fluorophore, the quencher molecule must be within a minimum quenching distance of the excited reporter molecule at some time prior to the reporter molecule releasing the stored fluorescence energy.</p>
    <p>Probes containing a reporter molecule--quencher molecule pair have been developed for hybridization assays where the probe forms a hairpin structure, i.e., where the probe hybridizes to itself to form a loop such that the quencher molecule is brought into proximity with the reporter molecule in the absence of a complementary nucleic acid sequence to prevent the formation of the hairpin structure. WO 90/03446; European Patent Application No. 0 601 889 A2. When a complementary target sequence is present, hybridization of the probe to the complementary target sequence disrupts the hairpin structure and causes the probe to adopt a conformation where the quencher molecule is no longer close enough to the reporter molecule to quench the reporter molecule. As a result, the probes provide an increased fluorescent signal when hybridized to a target sequence than when unhybridized. Probes including a hairpin structure have the disadvantage that they can be difficult to design and may interfere with the hybridization of the probe to the target sequence.</p>
    <p>Assays have also been developed for identifying the presence of a hairpin structure using two separate probes, one containing a reporter molecule and the other a quencher molecule. Mergney, et al, Nucleic Acids Research, 22:6 920-928 (1994). In these assays, the fluorescence signal of the reporter molecule decreases when hybridized to the target sequence due to the quencher molecule being brought into proximity with the reporter molecule.</p>
    <p>One particularly important application for probes including a reporter--quencher molecule pair is their use in nucleic acid amplification reactions, such as polymerase chain reactions (PCR), to detect the presence and amplification of a target nucleic acid sequence. In general, nucleic acid amplification techniques have opened broad new approaches to genetic testing and DNA analysis. Arnheim and Erlich, Ann. Rev. Biochem., 61: 131-156 (1992). PCR, in particular, has become a research tool of major importance with applications in, for example, cloning, analysis of genetic expression, DNA sequencing, genetic mapping and drug discovery. Amheim and Erlich, Ann. Rev. Biochem., 61: 131-156 (1992); Gilliland et al., Proc. Natl. Acad. Sci., 87: 2725-2729 (1990); Bevan et al., PCR Methods and Applications, 1: 222-228 (1992); Green et al., PCR Methods and Applications, 1: 77-90 (1991); Blackwell et al., Science, 250: 1104-1110 (1990).</p>
    <p>The widespread applications of nucleic acid amplification techniques has driven the development of instrumentation for carrying out the amplification reactions under a variety of circumstances. Important design goals for such instrument development have included fine temperature control, minimization of sample-to-sample variability in multi-sample thermal cycling, automation of pre- and post-reaction processing steps, high speed temperature cycling, minimization of sample volumes, real time measurement of amplification products and minimization of cross contamination, for example, due to "sample carryover". In particular, the design of instruments permitting amplification to be carried out in closed reaction chambers and monitored in real time would be highly desirable for preventing cross-contamination. Higuchi et al., Biotechnology, 10: 413-417 (1992) and 11: 1026-1030 (1993); and Holland et al., Proc. Natl. Acad. Sci., 88:7276-7280 (1991). Clearly, the successful realization of such a design goal would be especially desirable in the analysis of diagnostic samples, where a high frequency of false positives and false negatives, for example caused by "sample carryover", would severely reduce the value of an amplification procedure. Moreover, real time monitoring of an amplification reaction permits far more accurate quantification of starting target DNA concentrations in multiple-target amplifications, as the relative values of close concentrations can be resolved by taking into account the history of the relative concentration values during the reaction. Real time monitoring also permits the efficiency of the amplification reaction to be evaluated, which can indicate whether reaction inhibitors are present in a sample.</p>
    <p>Holland et al., (cited above), U.S. Pat. No. 5,210,015 to Gelfand, et al. and others have proposed fluorescence-based approaches to provide real time measurements of amplification products during PCR. Such approaches have either employed intercalating dyes (such as ethidium bromide) to indicate the amount of double-stranded DNA present, or they have employed probes containing fluorescence-quencher pairs (also referred to as the "Taq-Man" approach) where the probe is cleaved during amplification to release a fluorescent molecule whose concentration is proportional to the amount of double-stranded DNA present. During amplification, the probe is digested by the nuclease activity of a polymerase when hybridized to the target sequence to cause the fluorescent molecule to be separated from the quencher molecule, thereby causing fluorescence from the reporter molecule to appear.</p>
    <p>The Taq-Man approach, illustrated in FIG. 1, uses an oligonucleotide probe containing a reporter molecule--quencher molecule pair that specifically anneals to a region of a target polynucleotide "downstream", i.e. in the direction of extension of primer binding sites. The reporter molecule and quencher molecule are positioned on the probe sufficiently close to each other such that whenever the reporter molecule is excited, the energy of the excited state nonradiatively transfers to the quencher molecule where it either dissipates nonradiatively or is emitted at a different emission frequency than that of the reporter molecule. During strand extension by a DNA polymerase, the probe anneals to the template where it is digested by the 5'â†’3' exonuclease activity of the polymerase. As a result of the probe being digested, the reporter molecule is effectively separated from the quencher molecule such that the quencher molecule is no longer close enough to the reporter molecule to quench the reporter molecule's fluorescence. Thus, as more and more probes are digested during amplification, the number of reporter molecules in solution increases, thus resulting in an increasing number of unquenched reporter molecules which produce a stronger and stronger fluorescent signal.</p>
    <p>Three main factors influence the utility of reporter-quencher molecule pair probes in hybridization and amplification assays. The first factor is the effectiveness of the quencher molecule on the probe to quench the reporter molecule. This first factor, herein designated "RQ<sup>-</sup> ", can be characterized by the ratio of the fluorescent emissions of the reporter molecule to the quencher molecule when the probe is not hybridized to a complementary polynucleotide. That is, RQ<sup>-</sup>  is the ratio of the fluorescent emissions of the reporter molecule to the fluorescence of the quencher molecule when the oligonucleotide probe is in a single-stranded state. Influences on the value of RQ<sup>-</sup>  include, for example, the particular reporter and quencher molecules used, the spacing between the reporter and quencher molecules, nucleotide sequence-specific effects, and the degree of flexibility of structures, e.g., linkers, to which the reporter and quencher molecules are attached, and the presence of impurities. Wo et al., Anal. Biochem., 218: 1-13 (1994); and Clegg, Meth. Enzymol., 211: 353-388 (1992). A related quantity RQ<sup>30</sup> refers to the ratio of fluorescent emissions of the reporter molecule to the quencher molecule when the oligonucleotide probe is hybridized to a complementary polynucleotide.</p>
    <p>A second factor is the efficiency of the probe to hybridize to a complementary polynucleotide. This second factor depends on the probe's melting temperature, T<sub>m</sub>, the presence of a secondary structure in the probe or target polynucleotide, the annealing temperature, and other reaction conditions.</p>
    <p>A third factor is the efficiency with which the DNA polymerase 5'â†’3' exonuclease activity cleaves the bound probe between the reporter molecule and quencher molecule. This efficiency depends on such factors as the proximity of the reporter or quencher to the 5' end of the probe, the "bulkiness" of the reporter or quencher, and the degree of complementarity between the probe and target polynucleotide. Lee et al., Nucleic Acids Research, 21: 3761-3766 (1993).</p>
    <p>Since quenching depends on the physical proximity of the reporter molecule to the quencher molecule, it was previously assumed that the quencher and reporter molecules must be attached to the probe such that the quencher molecule remains at all times within the maximum distance at which the quencher molecule can quench the reporter molecule, this distance generally being a separation of about 6-16 nucleotides. Lee et al., Nucleic Acids Research, 21: 3761-3766 (1993); Mergny et al., Nucleic Acids Research 22: 920-928 (1994); Cardullo et al., Proc. Natl. Acad. Sci., 85: 8790-8794 (1988); Clegg et al., Proc. Natl. Acad. Sci., 90: 2994-2998 (1993); and Ozaki et al., Nucleic Acids Research, 20: 5205-5214 (1992). This short separation between the reporter molecule and the quencher molecule is typically achieved by attaching one member of the reporter-quencher pair to the 3' or 5' end of the probe and the other member to an internal base 6-16 nucleotides away.</p>
    <p>There are at least two significant disadvantages associated with attaching a reporter or quencher molecule to an internal base. Attaching a reporter or quencher molecule to an internal nucleotide typically involves more difficult chemistry than the chemistry required to attach the molecule to a terminal nucleotide. In addition, attachment of a reporter or quencher molecule to an internal nucleotide can adversely affect the hybridization efficiency of the probe. Ward et al., U.S. Pat. No. 5,328,824; and Ozaki et al. Nucleic Acids Research, 20: 5205-5214 (1992).</p>
    <p>A need currently exists for effective oligonucleotide probes containing a fluorescent reporter molecule and a quencher molecule for use in hybridization and nucleic acid amplification assays. Accordingly, a need exists for probes which exhibit distinguishable fluorescence characteristics when hybridized and not hybridized to a target nucleic acid sequence. A further need exists for probes where the reporter molecule and quencher molecule are positioned on the probe such that the quencher molecule can effectively quench the fluorescence of the reporter molecule. A further need exists for probes which are efficiently synthesized. Yet a further need exists for the reporter molecule and quencher molecule to be positionable on the probe such that the reporter and quencher molecules do not adversely impact the hybridization efficiency of probe. These and further objectives are provided by the probes and methods of the present invention.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>The present invention relates to an oligonucleotide probe which includes a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of the reporter molecule. According to the present invention, the oligonucleotide probe is constructed such that the probe exists in at least one single-stranded conformation when unhybridized where the quencher molecule is near enough to the reporter molecule to quench the fluorescence of the reporter molecule. The oligonucleotide probe also exists in at least one conformation when hybridized to a target polynucleotide where the quencher molecule is not positioned close enough to the reporter molecule to quench the fluorescence of the reporter molecule. By adopting these hybridized and unhybridized conformations, the reporter molecule and quencher molecule on the probe exhibit different fluorescence signal intensities when the probe is hybridized and unhybridized. As a result, it is possible to determine whether the probe is hybridized or unhybridized based on a change in the fluorescence intensity of the reporter molecule, the quencher molecule, or a combination thereof. In addition, because the probe can be designed such that the quencher molecule quenches the reporter molecule when the probe is not hybridized, the probe can be designed such that the reporter molecule exhibits limited fluorescence until the probe is either hybridized or digested.</p>
    <p>According to the present invention, the fluorescence intensity of the reporter molecule is preferably greater than the fluorescence intensity of the quencher molecule when the probe is hybridized to the target polynucleotide. The fluorescence intensity of the reporter molecule is more preferably at least about a factor of 3.5 greater than the fluorescence intensity of the quencher molecule when the probe is hybridized to the target polynucleotide.</p>
    <p>The fluorescence intensity of the oligonucleotide probe hybridized to the target polynucleotide is also preferably at least about a factor of 6 greater than the fluorescence intensity of the oligonucleotide probe when not hybridized to the target polynucleotide.</p>
    <p>The reporter molecule is preferably separated from the quencher molecule by at least about 15 nucleotides, more preferably at least about 18 nucleotides. The reporter molecule is preferably separated from the quencher molecule by between about 15 and 60 nucleotides, more preferably between about 18 and 30 nucleotides.</p>
    <p>The reporter molecule is preferably attached to either the 3' or 5' terminal nucleotides of the probe. The quencher molecule is also preferably attached to either the 3' or 5' terminal nucleotides of the probe. More preferably, the reporter and quencher molecules are attached to the 3' and 5' or 5' and 3' terminal nucleotides of the probe respectively.</p>
    <p>The reporter molecule is preferably a fluorescein dye and the quencher molecule is preferably a rhodamine dye.</p>
    <p>In one embodiment, the oligonucleotide probe of the present invention is immobilized on a solid support. The oligonucleotide probe may be attached directly to the solid support, for example by attachment of the 3' or 5' terminal nucleotide of the probe to the solid support. More preferably, however, the probe is attached to the solid support by a linker. The linker serves to distance the probe from the solid support. The linker is most preferably at least 30 atoms in length, more preferably at least 50 atoms in length.</p>
    <p>A wide variety of linkers are known in the art which may be used to attach the oligonucleotide probe to the solid support. The linker most preferably includes a functionalized polyethylene glycol because it does not significantly interfere with the hybridization of probe to the target oligonucleotide, is commercially available, soluble in both organic and aqueous media, easy to functionalize, and completely stable under oligonucleotide synthesis and post-synthesis conditions.</p>
    <p>The linkages between the solid support, the linker and the probe are preferably not cleaved during removal of base protecting groups under basic conditions at high temperature. Examples of preferred linkages include carbamate and amide linkages.</p>
    <p>The present invention also relates to the use of the oligonucleotide probe as a hybridization probe to detect target polynucleotides. Accordingly, the present invention relates to a hybridization assay for detecting the presence of a target polynucleotide in a sample. In one embodiment of the method, the hybridization probe is immobilized on a solid support.</p>
    <p>According to the method, an oligonucleotide probe of the present invention is contacted with a sample of polynucleotides under conditions favorable for hybridization. The fluorescence signal of the reporter molecule before and after being contacted with the sample is compared. Since the reporter molecule on the probe exhibits a greater fluorescence signal when hybridized to a target sequence, an increase in the fluorescence signal after the probe is contacted with the sample indicates the hybridization of the probe to target sequences in the sample, thereby indicating the pressure of target sequences in the sample. Quantification of the change in fluorescence intensity as a result of the probe being contacted with the sample can be used to quantify the amount of target sequences present in the sample.</p>
    <p>The present invention also relates to the use of the oligonucleotide probe for monitoring nucleic acid amplification. Accordingly, the present invention relates to a method for monitoring nucleic acid amplification by performing nucleic acid amplification on a target sequence using a nucleic acid polymerase having 5'â†’3' nuclease activity, a primer capable of hybridizing to the target sequence and an oligonucleotide probe according to the present invention which is capable of hybridizing to the target sequence 3' relative to the primer. According to the method, the nucleic acid polymerase digests the oligonucleotide probe during amplification when it is hybridized to the target sequence, thereby separating the reporter molecule from the quencher molecule. As the amplification is conducted, the fluorescence of the reporter molecule is monitored, the generation of fluorescence corresponding to the occurrence of nucleic acid amplification. Accordingly, the amount of amplification performed can be quantified based on the change in fluorescence observed. It is noted that the fluorescence of the quencher molecule may also be monitored, either separately or in combination with the reporter molecule, to detect amplification.</p>
    <heading>BRIEF DESCRIPTION OF THE FIGURES</heading> <p>FIG. 1 illustrates a method for real-time monitoring nucleic acid amplification utilizing a probe which is degraded by the 5'â†’3' exonuclease activity of a nucleic acid polymerase.</p>
    <p>FIG. 2 illustrates a probe according to the present invention immobilized to a solid support in hybridized and unhybridized conformations.</p>
    <p>FIG. 3 illustrates the functionalization of compound 5.</p>
    <p>FIG. 4 illustrates the attachment of the spacer to polystyrene and CPG supports.</p>
    <p>FIG. 5 illustrates the labeling of the solid supports with TAMRA dye.</p>
    <heading>DETAILED DESCRIPTION</heading> <p>The present invention relates to an oligonucleotide probe which includes a fluorescent reporter molecule and a quencher molecule capable of quenching the fluorescence of the reporter molecule. According to the present invention, the oligonucleotide probe is constructed such that the probe exists in at least one single-stranded conformation when unhybridized where the quencher molecule is near enough to the reporter molecule to quench the fluorescence of the reporter molecule. The oligonucleotide probe also exists in at least one conformation when hybridized to a target polynucleotide such that the quencher molecule is not positioned close enough to the reporter molecule to quench the fluorescence of the reporter molecule. By adopting these hybridized and unhybridized conformations, the reporter molecule and quencher molecule on the probe exhibit different fluorescence signal intensities when the probe is hybridized and unhybridized. As a result, it is possible to determine whether the probe is hybridized or unhybridized based on a change in the fluorescence intensity of the reporter molecule, the quencher molecule, or a combination thereof. In addition, because the probe can be designed such that the quencher molecule quenches the reporter molecule when the probe is not hybridized, the probe can be designed such that the reporter molecule exhibits limited fluorescence unless the probe is either hybridized or digested.</p>
    <p>According to the present invention, the fluorescence intensity of the reporter molecule is preferably greater than the fluorescence intensity of the quencher molecule when the probe is hybridized to the target polynucleotide. The fluorescence intensity of the reporter molecule is more preferably at least about a factor of 3.5 greater than the fluorescence intensity of the quencher molecule when the probe is hybridized to the target polynucleotide.</p>
    <p>The fluorescence intensity of the oligonucleotide probe hybridized to the target polynucleotide is also preferably at least about a factor of 6 greater than the fluorescence intensity of the oligonucleotide probe when not hybridized to the target polynucleotide.</p>
    <p>The reporter molecule is preferably separated from the quencher molecule by at least about 15 nucleotides, more preferably at least about 18 nucleotides. The reporter molecule is preferably separated from the quencher molecule by between about 15 and 60 nucleotides, more preferably between about 18 and 30 nucleotides.</p>
    <p>The reporter molecule is preferably attached to either the 3' or 5' terminal nucleotides of the probe. The quencher molecule is also preferably attached to either the 3' or 5' terminal nucleotides of the probe. More preferably, the reporter and quencher molecules are attached to the 3' and 5' or 5' and 3' terminal nucleotides of the probe respectively.</p>
    <p>The reporter molecule is preferably a fluorescein dye and the quencher molecule is preferably a rhodamine dye.</p>
    <p>In one embodiment, the oligonucleotide probe is attached to a solid support. As illustrated in FIG. 2, when the probe is unhybridized, the probe is able to adopt at least one single-stranded conformation such that the quencher molecule is near enough to the reporter molecule to quench the fluorescence of the reporter molecule. As further illustrated in FIG. 2, when the probe is hybridized to a target sequence, the probe adopts at least one conformation where the quencher molecule is not positioned close enough to the reporter molecule to quench the fluorescence of the reporter molecule. As a result, the fluorescence intensity of the reporter molecule increases when the probe hybridizes to a target sequence.</p>
    <p>As illustrated in FIG. 2, different probes may be attached to the solid support and may be used to simultaneously detect different target sequences in a sample. Reporter molecules having different fluorescence wavelengths can be used on the different probes, thus enabling hybridization to the different probes to be separately detected.</p>
    <p>Examples of preferred types of solid supports for immobilization of the oligonucleotide probe include controlled pore glass, glass plates, polystyrene, avidin coated polystyrene beads, cellulose, nylon, acrylamide gel and activated dextran. CPG, glass plates and high cross-linked polystyrene. These solid supports are preferred for hybridization and diagnostic studies because of their chemical stability, ease of functionalization and well defined surface area. Solid supports such as controlled pore glass (CPG, 500 â„«, 1000 â„«) and non-swelling high cross-linked polystyrene (1000 â„«) are particularly preferred in view of their compatibility with oligonucleotide synthesis.</p>
    <p>The oligonucleotide probe may be attached to the solid support in a variety of manners. For example, the probe may be attached to the solid support by attachment of the 3' or 5' terminal nucleotide of the probe to the solid support. More preferably, however, the probe is attached to the solid support by a linker which serves to distance the probe from the solid support. The linker is most preferably at least 30 atoms in length, more preferably at least 50 atoms in length.</p>
    <p>The length and chemical stability of linker between solid support and the first 3' unit of oligonucleotides play an important role in efficient synthesis and hybridization of support bound oligonucleotides. The linker arm should be sufficiently long so that a high yield (&gt;97%) can be achieved during automated synthesis. The required length of the linker will depend on the particular solid support used. For example, a six atom linker is generally sufficient to achieve a &gt;97% yield during automated synthesis of oligonucleotides when high cross-linked polystyrene is used as the solid support. The linker arm is preferably at least 20 atoms long in order to attain a high yield (&gt;97%) during automated synthesis when CPG is used as the solid support.</p>
    <p>Hybridization of a probe immobilized to a solid support generally requires that the probe be separated from the solid support by at least 30 atoms, more preferably at least 50 atoms. In order to achieve this separation, the linker generally includes a spacer positioned between the linker and the 3' nucleoside. For oligonucleotide synthesis, the linker arm is usually attached to the 3'--OH of the 3' nucleoside by an ester linkage which can be cleaved with basic reagents to free the oligonucleotide from the solid support.</p>
    <p>A wide variety of linkers are known in the art which may be used to attach the oligonucleotide probe to the solid support. The linker may be formed of any compound which does not significantly interfere with the hybridization of the target sequence to the probe attached to the solid support. The linker may be formed of a homopolymeric oligonucleotide which can be readily added on to the linker by automated synthesis. Alternatively, polymers such as functionalized polyethylene glycol can be used as the linker. Such polymers are preferred over homopolymeric oligonucleotides because they do not significantly interfere with the hybridization of probe to the target oligonucleotide. Polyethylene glycol is particularly preferred because it is commercially available, soluble in both organic and aqueous media, easy to functionalize, and completely stable under oligonucleotide synthesis and post-synthesis conditions.</p>
    <p>The linkages between the solid support, the linker and the probe are preferably not cleaved during removal of base protecting groups under basic conditions at high temperature. Examples of preferred linkages include carbamate and amide linkages.</p>
    <p>The oligonucleotide probe of the present invention may be used as a hybridization probe to detect target polynucleotides. Accordingly, the present invention relates to a hybridization assay for detecting the presence of a target polynucleotide in a sample. According to the method, an oligonucleotide probe of the present invention is contacted with a sample of nucleic acids under conditions favorable for hybridization. The fluorescence signal of the reporter molecule is measured before and after being contacted with the sample. Since the reporter molecule on the probe exhibits a greater fluorescence signal when hybridized to a target sequence, an increase in the fluorescence signal after the probe is contacted with the sample indicates the hybridization of the probe to target sequences in the sample and hence the presence of target sequences in the sample. Further, by quantifying the change in fluorescence intensity as a result of the probe being contacted with the sample, the amount of target sequences in the sample can be quantified.</p>
    <p>According to one embodiment of the method, the hybridization probe is immobilized on a solid support. The oligonucleotide probe is contacted with a sample of nucleic acids under conditions favorable for hybridization. The fluorescence signal of the reporter molecule is measured before and after being contacted with the sample. Since the reporter molecule on the probe exhibits a greater fluorescence signal when hybridized to a target sequence, an increase in the fluorescence signal after the probe is contacted with the sample indicates the hybridization of the probe to target sequences in the sample. Immobilization of the hybridization probe to the solid support enables the target sequence hybridized to the probe to be readily isolated from the sample. In later steps, the isolated target sequence may be separated from the solid support and processed (e.g., purified, amplified) according to methods well known in the art depending on the particular needs of the researcher.</p>
    <p>The oligonucleotide probe of the present invention may also be used as a probe for monitoring nucleic acid amplification. Accordingly, the present invention relates to a method for monitoring nucleic acid amplification using an oligonucleotide probe according to the present invention which is capable of hybridizing to the target sequence 3' relative to an amplification primer. According to the method, nucleic acid amplification is performed on a target polynucleotide using a nucleic acid polymerase having 5'â†’3' nuclease activity, a primer capable of hybridizing to the target polynucleotide, and an oligonucleotide probe according to the present invention capable of hybridizing to the target polynucleotide 3' relative to the primer. During amplification, the nucleic acid polymerase digests the oligonucleotide probe when it is hybridized to the target sequence, thereby separating the reporter molecule from the quencher molecule. As the amplification is conducted, the fluorescence of the reporter molecule is monitored, the generation of fluorescence corresponding to the occurrence of nucleic acid amplification.</p>
    <p>Use of a reporter-quencher pair probe generally in conjunction with the amplification of a target polynucleotide, for example, by PCR, e.g., is described in many references, such as Innis et al., editors, PCR Protocols (Academic Press, New York, 1989); Sambrook et al., Molecular Cloning, Second Edition (Cold Spring Harbor Laboratory, New York, 1989), each of which are incorporated herein by reference. The binding site of the oligonucleotide probe is located between the PCR primers used to amplify the target polynucleotide. Preferably, PCR is carried out using Taq DNA polymerase, e.g., AMPLITAQâ„¢ (Perkin-Elmer, Norwalk, Conn.), or an equivalent thermostable DNA polymerase, and the annealing temperature of the PCR is about 5Â°-10Â° C. below the melting temperature of the oligonucleotide probes employed.</p>
    <p>Use of an oligonucleotide probe according to the present invention for monitoring nucleic acid amplification provides several advantages over the use of prior art reporter-quencher pair probes. For example, prior art probes required that the reporter and quencher molecules be positioned on the probe such that the quencher molecule remained within a minimum quenching distance of the reporter molecule. However, by realizing that the probe need only be designed such that the probe be able to adopt a conformation where the quencher molecule is within a minimum quenching distance of the reporter molecule, a far wider array of probes are enabled. For example, dually labelled probes having the reporter and quencher molecules at the 5' and 3' ends can be designed. Such probes are far easier to synthesize than probes where the reporter molecule or the quencher molecule is attached to an internal nucleotide. Positioning of the reporter and quencher molecules on terminal nucleotides also enhances the hybridization efficiency of the probes.</p>
    <p>As used in this application, the term "oligonucleotide", includes linear oligomers of natural or modified monomers or linkages, including deoxyribonucleosides, ribonucleosides, and the like; capable of specifically binding a target polynucleotide by way of a regular pattern of monomer-to-monomer interactions, such as Watson-Crick type of basepairing, or the like. Usually monomers are linked by phosphodiester bonds or analogs thereof to form oligonucleotides ranging in size from a few monomeric units, e.g., 3-4, to several tens of monomeric units. Whenever an oligonucleotide is represented by a sequence of letters, such as "ATGCCTG", it will be understood that the nucleotides are in 5'â†’3' order from left to right and that "A" denotes deoxyadenosine, "C" denotes deoxycytidine, "G" denotes deoxyguanosine, and "T" denotes thymidine, unless otherwise noted. Analogs of phosphodiester linkages include phosphorothioate, phosphorodithioate, phosphoranilidate, phosphoramidate, and the like. Generally, oligonucleotide probes of the invention will have a sufficient number of phosphodiester linkages adjacent to its 5' end so that the 5'â†’3' exonuclease activity employed can efficiently degrade the bound probe to separate the reporter and quencher molecules.</p>
    <p>"Perfectly matched" in reference to a duplex means that the poly- or oligonucleotide strands making up the duplex form a double-stranded structure with one other such that every nucleotide in each strand undergoes Watson-Crick basepairing with a nucleotide in the other strand. The term also comprehends the pairing of nucleoside analogs, such as deoxyinosine, nucleosides with 2-aminopurine bases, and the like, that may be employed. Conversely, a "mismatch" in a duplex between a target polynucleotide and an oligonucleotide probe or primer means that a pair of nucleotides in the duplex fails to undergo Watson-Crick bonding.</p>
    <p>As used in the application, "nucleoside" includes the natural nucleosides, including 2'-deoxy and 2'-hydroxyl forms, e.g., as described in Kornberg and Baker, DNA Replication, 2nd Ed. (Freeman, San Francisco, 1992). "Analogs" in reference to nucleosides includes synthetic nucleosides having modified base moieties and/or modified sugar moieties, e.g., described by Scheit, Nucleotide Analogs (John Wiley, New York, 1980); Uhlman and Peyman, Chemical Reviews, 90: 543-584 (1990), or the like, with the only proviso that they are capable of specific hybridization. Such analogs include synthetic nucleosides designed to enhance binding properties, reduce degeneracy, increase specificity, and the like.</p>
    <p>Oligonucleotide probes of the invention can be synthesized by a number of approaches, e.g., Ozaki et al., Nucleic Acids Research, 20: 5205-5214 (1992); Agrawal et al., Nucleic Acids Research, 18: 5419-5423 (1990); or the like. The oligonucleotide probes of the invention are conveniently synthesized on an automated DNA synthesizer, e.g., an Applied Biosystems, Inc. (Foster City, Calif.) model 392 or 394 DNA/RNA Synthesizer, using standard chemistries, such as phosphoramidite chemistry, e.g., disclosed in the following references: Beaucage and lyer, Tetrahedron, 48: 2223-2311 (1992); Molko et al., U.S. Pat. No. 4,980,460; Koster et al., U.S. Pat. No. 4,725,677; Caruthers et al., U.S. Pat. Nos. 4,415,732; 4,458,066; and 4,973,679; and the like. Alternative chemistries, e.g., resulting in non-natural backbone groups, such as phosphorothioate, phosphoramidate, and the like, may also be employed provided that the hybridization efficiencies of the resulting oligonucleotides and/or cleavage efficiency of the exonuclease employed are not adversely affected.</p>
    <p>Preferably, the oligonucleotide probe is in the range of 15-60 nucleotides in length. More preferably, the oligonucleotide probe is in the range of 18-30 nucleotides in length. The precise sequence and length of an oligonucleotide probe of the invention depends in part on the nature of the target polynucleotide to which it binds. The binding location and length may be varied to achieve appropriate annealing and melting properties for a particular embodiment. Guidance for making such design choices can be found in many of the above-cited references describing the "Taq-man" type of assays.</p>
    <p>Preferably, the 3' terminal nucleotide of the oligonucleotide probe is blocked or rendered incapable of extension by a nucleic acid polymerase. Such blocking is conveniently carried out by the attachment of a reporter or quencher molecule to the terminal 3' carbon of the oligonucleotide probe by a linking moiety.</p>
    <p>Preferably, reporter molecules are fluorescent organic dyes derivatized for attachment to the terminal 3' carbon or terminal 5' carbon of the probe via a linking moiety. Preferably, quencher molecules are also organic dyes, which may or may not be fluorescent, depending on the embodiment of the invention. For example, in a preferred embodiment of the invention, the quencher molecule is fluorescent. Generally whether the quencher molecule is fluorescent or simply releases the transferred energy from the reporter by non-radiative decay, the absorption band of the quencher should substantially overlap the fluorescent emission band of the reporter molecule. Non-fluorescent quencher molecules that absorb energy from excited reporter molecules, but which do not release the energy radiatively, are referred to in the application as chromogenic molecules.</p>
    <p>There is a great deal of practical guidance available in the literature for selecting appropriate reporter-quencher pairs for particular probes, as exemplified by the following references: Clegg (cited above); Wu et al. (cited above); Pesce et al., editors, Fluorescence Spectroscopy (Marcel Dekker, New York, 1971); White et al., Fluorescence Analysis: A Practical Approach (Marcel Dekker, New York, 1970); and the like. The literature also includes references providing exhaustive lists of fluorescent and chromogenic molecules and their relevant optical properties for choosing reporter-quencher pairs, e.g., Berlman, Handbook of Fluorescence Spectra of Aromatic Molecules, 2nd Edition (Academic Press, New York, 1971); Griffiths, Color and Constitution of Organic Molecules (Academic Press, New York, 1976); Bishop, editor, Indicators (Pergamon Press, Oxford, 1972); Haugland, Handbook of Fluorescent Probes and Research Chemicals (Molecular Probes, Eugene, 1992) Pringsheim, Fluorescence and Phosphorescence (Interscience Publishers, New York, 1949); and the like. Further, there is extensive guidance in the literature for derivatizing reporter and quencher molecules for covalent attachment via common reactive groups that can be added to an oligonucleotide, as exemplified by the following references: Haugland (cited above); Ullman et al., U.S. Pat. No. 3,996,345; Khanna et al., U.S. Pat. No. 4,351,760; and the like.</p>
    <p>Exemplary reporter-quencher pairs may be selected from xanthene dyes, including fluoresceins, and rhodamine dyes. Many suitable forms of these compounds are widely available commercially with substituents on their phenyl moieties which can be used as the site for bonding or as the bonding functionality for attachment to an oligonucleotide. Another group of fluorescent compounds are the naphthylamines, having an amino group in the alpha or beta position. Included among such naphthylamino compounds are 1-dimethylaminonaphthyl-5-sulfonate, 1-anilino-8-naphthalene sulfonate and 2-p-touidinyl-6-naphthalene sulfonate. Other dyes include 3-phenyl-7-isocyanatocoumarin, acridines, such as 9-isothiocyanatoacridine and acridine orange; N-(p-(2-benzoxazolyl)phenyl)maleimide; benzoxadiazoles, stilbenes, pyrenes, and the like.</p>
    <p>Preferably, reporter and quencher molecules are selected from fluorescein and rhodamine dyes. These dyes and appropriate linking methodologies for attachment to oligonucleotides are described in many references, e.g., Khanna et al. (cited above); Marshall, Histochemical J., 7: 299-303 (1975); Menchen et al., U.S. Pat. No. 5,188,934; Menchen et al., European Patent Application 87310256.0; and Bergot et al., International Application PCT/US90/05565The latter four documents are hereby incorporated by reference.</p>
    <p>There are many linking moieties and methodologies for attaching reporter or quencher molecules to the 5' or 3' termini of oligonucleotides, as exemplified by the following references: Eckstein, editor, Oligonucleotides and Analogues: A Practical Approach (IRL Press, Oxford, 1991); Zuckerman et al., Nucleic Acids Research, 15: 5305-5321 (1987) (3' thiol group on oligonucleotide); Sharma et al., Nucleic Acids Research, 19: 3019 (1991) (3' sulfhydryl); Giusti et al., PCR Methods and Applications, 2: 223-227 (1993) and Fung et al., U.S. Pat. No.4, 757,141 (5' phosphoamino group via AMINOLINKâ„¢ II available from Applied Biosystems, Foster City, Calif.) Stabinsky, U.S. Pat. No. 4,739,044 (3' aminoalkylphosphoryl group); Agrawal et al., Tetrahedron Letters, 31: 1543-1546 (1990) (attachment via phosphoramidate linkages); Sproat et al., Nucleic Acids Research, 15: 4837 (1987) (5' mercapto group); Nelson et al., Nucleic Acids Research, 17: 7187-7194 (1989) (3' amino group); and the like.</p>
    <p>Preferably, commercially available linking moieties are employed that can be attached to an oligonucleotide during synthesis, e.g., available from Clontech Laboratories (Palo Alto, Calif.).</p>
    <p>Rhodamine and fluorescein dyes are also conveniently attached to the 5' hydroxyl of an oligonucleotide at the conclusion of solid phase synthesis by way of dyes derivatized with a phosphoramidite moiety, e.g., Woo et al., U.S. Pat. No. 5,231, 191; and Hobbs, Jr., U.S. Pat. No. 4,997,928</p>
    <p>The following examples set forth probes and methods for using the probes according to the present invention. It is understood that the specific probes, probe constructs and steps of the methods described in these examples are not intended to be limiting. Further objectives and advantages of the present invention other than those set forth above will become apparent from the examples which are not intended to limit the scope of the present invention.</p>
    <heading>EXAMPLES</heading> <p>1. Synthesis of Oligonucleotide Probes</p>
    <p>The following example describes the synthesis of the oligonucleotides shown in Table 1Linker arm nucleotide ("LAN") phosphoramidite was obtained from Glen Research. Standard DNA phosphoramidites, 6-carboxyfluorescein ("6-FAM") phosphoramidite, 6-carboxytetramethylrhodamine succinimidyl ester ("TAMRA NHS ester"), and PHOSPHALINKâ„¢ for attaching a 3' blocking phosphate were obtained from Perkin-Elmer, Applied Biosystems Division. Oligonucleotide synthesis was performed on a model 394 DNA Synthesizer (Applied Biosystems). Primer and complement oligonucleotides were purified using Oligo Purification Cartridges (Applied Biosystems). Doubly labeled probes were synthesized with 6-FAM-labeled phosphoramidite at the 5' end, LAN replacing one of the T's in the oligonucleotide sequence, and PHOSPHALINKâ„¢ at the 3' end. Following deprotection and ethanol precipitation, TAMRA NHS ester was coupled to the LAN-containing oligonucleotide in 250 mM Na-bicarbonate buffer (pH 9.0) at room temperature. Unreacted dye was removed by passage over a PD-10 Sephadex column. Finally, the doubly labeled probe was purified by preparative HPLC using standard protocols. Below, probes are named by designating the sequence from Table 1 and the position of the LAN-TAMRA moiety. For example, probe A1-7 has sequence of A1 with LAN-TAMRA at nucleoside position 7 from the 5' end.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 1______________________________________Sequences of oligonucleotidesName Type      Sequence______________________________________F119 primer    ACCCACAGGAACTGATCACCACTC           SEQ. ID. No.: 1!R119 primer    ATGTCGCGTTCCGGCTGACGTTCTGC           SEQ. ID. No.: 2!P2   probe     TCGCATTACTGATCGTTGCCAACCAGTp           SEQ. ID. No.: 3!P2C  complement          GTACTGGTTGGCAACGATCAGTAATGCGATG           SEQ. ID. No.: 4!P5   probe     CGGATTTGCTGGTATCTATGACAAGGATp           SEQ. ID. No.: 5!P5C  complement          TTCATCCTTGTCATAGATACCAGCAAATCCG           SEQ. ID. No.: 6!AFP  primer    TCACCCACACTGTGCCCATCTACGA           SEQ. ID. No.: 7!ARP  primer    CAGCGGAACCGCTCATTGCCAATGG           SEQ. ID. No.: 8!A1   probe     ATGCCCTCCCCCATGCCATCCTGCGTp           SEQ. ID. No.: 9!A1C  complement          AGACGCAGGATGGCATGGGGGAGGGCATAC           SEQ. ID. No.: 10!A3   probe     CGCCCTGGACTTCGAGCAAGAGATp           SEQ. ID. No.: 11!A3C  complement          CCATCTCTTGCTCGAAGTCCAGGGCGAC           SEQ. ID. No.: 12!G1   probe     CAAGCTTCCCGTTCTCAGCCT           SEQ. ID. No.: 13!G1C  complement          ACCGTCAAGGCTGAGAACGGGAAGCTTGTC           SEQ. ID. No.: 14!______________________________________</pre>
    
    <p>2. Synthesis of Oligonucleotide Probes Attached To A Solid Support</p>
    <p>Both high cross-linked polystyrene (1000 â„«) and controlled pore glass (CPG) (500 â„«) are used as solid support matrices. The functionalization of a spacer (compound 5) is illustrated in FIG. 3. The attachment of the spacer to polystyrene and CPG supports, and the labelling of the solid supports with TAMRA dye is shown in FIGS. 4 and 5 respectively.</p>
    <p>FIG. 3 illustrates a reaction scheme for the synthesis of a spacer, compound 5, which is used to derivatize CPG and polystyrene supports. As shown in Table 2, N-Fmoc-Îµ-aminocaproic acid was reacted with DL-homoserine in presence of HOBT/HBTU/DIPEA (Knorr, et al., Tetrahedron Lett. 1989, 30,1927) in DMF to give compound 2 in 65% yield. Compound 2 was reacted with dimethoxytrityl chloride in presence of DMAP in pyridine to give compound 3 in 72% yield after chromatography. Treatment of compound 3 with a large excess of PEG-diamine (Buckmann, et al., Biotech. Appl. Biochem. 1987, 9, 258) in presence of HOBT/HBTU/DIPEA in DMF afforded amine 4 in 60% yield. The amine 4 was then converted to succinate 5 by treating amine 4 with succinic anhydride/Et<sub>3</sub> N/DMAP in CH<sub>2</sub> Cl<sub>2</sub> in 90% yield. The succinate 5 was then attached to polystyrene and CPG support as illustrated in Tables 3 and 4 respectively without further purification.</p>
    <p>As illustrated in FIGS. 4 and 5, succinate 5 was separately reacted with polystyrene and CPG support in presence of HOBT/HBTU/DIPEA in DMF to provide functionalized support 6 (5 Î¼mol/g loading) and functionalized support 8 (15 Î¼mol/g loading) respectively. The Fmoc group was removed from support bound spacer by treating supports 6 and 8 with 20% piperidine in DMF (Fields, et al., J. Peptide Res. 1990, 35, 161) to give amine which was reacted with TAMRA NHS ester to give TAMRA labeled supports 7 and 9 respectively. The polystyrene and CPG supports showed a final loading of 4.8 Î¼mol/g and 14 Î¼mol/g respectively by trityl cation assay.</p>
    <p>Double labeled Taqman probe was synthesized using both TAMRA labeled supports 7 and 9, FastPhoramidites (User Bulletin Number 85, Perkin Elmer Corporation 1994) and FAM phosphoramidite (User Bulletin Number 78, Perkin Elmer Corporation 1994) in 40 nanomol scale. The support bound oligonucleotides were deprotected by treating with MeOH:t-BuNH<sub>2</sub> :H<sub>2</sub> O (1:1:2) at 65Â° C. for 3 hours (Woo, et al., U.S. Pat. No. 5,231,191). Liquid was removed and the support containing probes were washed with H<sub>2</sub> O:MeOH (3:1) and MeOH. The support was then dried under vacuum and used in a hybridization assay.</p>
    <p>Experimental:</p>
    <p>Compound 2: N,N-Diisopropylethylamine (1.1 g, 1.48 mL, 8.52 mmol), 1-hydroxybenzotriazol (420 mg, 3.1 mmol) and (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (1.17 g, 3.1 mmol) were added to a stirred solution of Nfmoc-Îµ-aminocaproic acid (1 g, 2.84 mmol) in DMF (30 mL) at room temperature. After 15 min DL-homoserine (1.35 g, 11.36 mmol) was added to the reaction mixture. After 3 hours, DMF was removed under reduced pressure. The residue was dissolved in CHCl<sub>3</sub> (100 mL) and washed with 5% aqueous HCl (2Ã—50 mL). The organic layer was dried over MgSO<sub>4</sub> and evaporated to give a thick oil which was trituated with ether to give a colorless solid (840 mg, 65%). The product was left under high vacuum for 24 hours and used in the next step without further purification.</p>
    <p>Compound 3: 4,4'-Dimethoxytrityl chloride (484 mg, 1.43 mmol) and 4-dimethyaminopyridine (25 mg, 0.2 mmol) were added to a stirred solution of compound 2 (500 mg, 1.1 mmol) in pyridine (15 mL) at room temperature under nitrogen atmosphere. After 14 hours, pyridine was removed and the residue was dissolved in CHCl<sub>3</sub> (70 mL). The organic layer was extracted with 5% aqueous citric acid (1Ã—50 mL), H<sub>2</sub> O (1Ã—50 mL) and saturated brine (1Ã—50 mL). The organic layer was dried over MgSO<sub>4</sub> and evaporated to give a yellow foam. The product was purified by a silica gel column eluting with CHCl<sub>3</sub> -MeOH gradient (0-10% MeOH). The appropriate fractions were combined and evaporated to give Compound 3 as a colorless foam (600 mg, 72%).</p>
    <p>Compound 4: Poly(ethylene glycol) bis(2-aminoethyl ether) (3.16 g, 5.3 mmol), N,N-diisopropylethylamine (205 mg, 0.27 mL, 1.59 mmol), 1-hydroxybenzotriazol (78 mg, 0.58 mmol) and (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluonium hexafluorophosphate (220 mg, 0.58 mmol) were added to a stirred solution of compound 3 (400 mg, 0.53 mmol) in DMF (10 mL) at room temperature. The reaction mixture was stirred at room temperature for 3 hours. DMF was removed under reduced pressure and, the residue was dissolved in CHCl<sub>3</sub> (70 mL) and washed with H<sub>2</sub> O (1Ã—50 mL) and saturated brine (2Ã—50 mL). The organic layer was dried over MgSO<sub>4</sub> and evaporated to give a thick oil. Compound 4 was purified by a silica gel column eluting with a CHCl<sub>3</sub> -MeOH gradient (5-15% MeOH) as a colorless glass (423 mg, 60%).</p>
    <p>Compound 5: Succinic anhydride (22 mg, 0.22 mmol), Et<sub>3</sub> N (23 mg, 0.31 Î¼L, 0.22 mmol), 4-dimethylaminopyridine (14 mg, 0.11 mmol) were added to a solution of compound 4 (300 mg, 0.22 mmol) in CH<sub>2</sub> Cl<sub>2</sub> (15 mL). The reaction mixture was stirred at room temperature for 3 hours. The reaction mixture was diluted with CHCl<sub>3</sub> (30 mL) and washed with 5% aqueous citric acid (1Ã—50 mL) and saturated brine (2Ã—50 mL). The organic layer was dried over MgSO<sub>4</sub> and evaporated to a colorless foam (284 mg, 90%) which was used for derivatization of the solid support without further purification.</p>
    <p>Derivatization of Polystyrene support with TAMRA dye: High cross linked polystyrene (1000 â„«, 10 Î¼mol/g amine loading, 1 g, 10 Î¼mol), was treated with compound 5 (17 mg, 12 Î¼mol, 1-hydroxybenzotriazol (1.8 mg, 12 Î¼mol), (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluonium hexafluorophosphate (4.8 mg, 12 Î¼mol), N,N-diisopropylethylamine (6 Î¼L, 30 Î¼mol) in DMF (10 mL) on a wrist action shaker for 4 hours at room temperature. The support was washed with DMF (3Ã—10 mL), CH<sub>3</sub> CN (2Ã—10 mL) and CH<sub>2</sub> Cl<sub>2</sub> (1Ã—10 mL) and dried under high vacuum overnight. The ninhydrin assay showed 1 Î¼mol/g amine left. The trityl cation assay gave 5 Î¼mol/g loading of compound 5The support was capped with acetic anhydride/lutidine in THF (10% solution, 5 mL) and 1-methylimidazol in THF (16% solution, 5 mL) for 2 hours at room temperature. The support was washed with CH<sub>3</sub> CN (3Ã—10 mL) and CH<sub>2</sub> Cl<sub>2</sub> (1Ã—10 mL). The support was treated with 20% piperidine in DMF (3Ã—10 mL) to remove the Fmoc protecting group. The removal of the Fmoc group was monitored by measuring UV of the solution at 302 nm. The support was washed with DMF (3Ã—10 mL) and, then treated with TAMRA NHS ester (15 mg, 27 Î¼mol) and Et<sub>3</sub> N (50 Î¼mol) in DMF (10 mL) for 42 hours on a shaker. The support was washed with DMF (3Ã—10 mL) CH<sub>3</sub> CN (2Ã—10 mL) and CH<sub>2</sub> Cl<sub>2</sub> (1Ã—10 mL) and dried under high vacuum for 24 hours. Ninhydrin test showed less than 0.5 Î¼mol/g amine left. The support was capped with acetic anhydride/lutidine in THF (10% solution, 5 mL) and 1-methylimidazol in THF (16% solution, 5 mL) for 1 hour and then washed with CH<sub>3</sub> CN (3Ã—10 mL), CH<sub>2</sub> Cl<sub>2</sub> (2Ã—10 mL) and dried under high vacuum for 24 hour. The trityl cation assay showed a final loading of 4.8 Î¼mol/g.</p>
    <p>Derivatization of CPG support with TAMRA dye: A mixture of CPG (500 â„«, 40 Î¼mol/g amine loading, 500 mg, 20 Î¼mol), compound 5 (31 mg, 22 Î¼mol), 1-hydroxybenzotriazol (5.9 mg, 22 Î¼mol), (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexaflurophosphate (8.4 mg, 22 Î¼mol), N,N-diisopropylethylamine (10.4 Î¼L, 60 Î¼mol) in DMF (10 mL) was shaken on a wrist action shaker for 4 hours at room temperature. The support was washed with DMF (3Ã—10 mL), CH<sub>3</sub> CN (2Ã—10 mL) and CH<sub>2</sub> Cl<sub>2</sub> (1Ã—10 mL) and dried under high vacuum overnight. The ninhydrin assay showed 4 Î¼mol/g amine left. The trityl assay gave 15 Î¼mol/g loading of compound 5 on CPG support. The support was capped with acetic anhydride/lutidine in THF (10% solution, 5 mL) and 1-methylimidazol in THF (16% solution, 5 mL) for 2 hours at room temperature. The support was washed with CH<sub>3</sub> CN (3Ã—10 mL) and CH<sub>2</sub> Cl<sub>2</sub> (1Ã—10 mL). The support was treated with 20% piperidine in DMF (3Ã—10 mL) to remove the Fmoc protecting group. Removal of the Fmoc group was monitored by measuring UV of the solution at 302 nm. The support was washed with DMF (3Ã—10 mL). The support was then treated with TAMRA NHS ester (25 mg, 45 Î¼mol) and Et<sub>3</sub> N (90 Î¼mol) in DMF (5 mL) for 42 hours on a shaker. The support was washed with DMF (3Ã—10 mL), CH<sub>3</sub> CN (2Ã—10 mL) and CH<sub>2</sub> Cl<sub>2</sub> (1Ã—10 mL) and dried under high vacuum for 24 hours. Ninhydrin test showed less than 1 Î¼mol/g amine left. The support was capped with acetic anhydride/lutidine in THF (10% solution, 5 mL) and 1-methylimidazol in THF (16% solution, 5 mL) for 1 hour and then washed with CH<sub>3</sub> CN (3Ã—10 mL), CH<sub>2</sub> Cl<sub>2</sub> (2Ã—10 mL) and dried under high vacuum for 24 hours. The trityl cation assay showed a final loading of 14 Î¼mol/g.</p>
    <p>Synthesis of FAM and TAMRA Doubled Labeled Probes: Doubled dye labeled oligonucleotide probe were synthesized by using TAMRA labelled supports 7 and 9, DNA FastPhosphoramidite and FAM amidite in 40 nmol scale. After completion of synthesis, supports containing probes were transferred to 4 mL glass vials and treated with a mixture of MeOH:t-BuNH<sub>2</sub> :H<sub>2</sub> O (1:1:2) at 65Â° C. for 3 hours. Liquid was removed by a syringe and the support was washed with H<sub>2</sub> O:MeOH (3:1) and MeOH. The support was dried under vacuum and used in the hybridization assay.</p>
    <p>3. Hybridization Assay Using Oligonucleotide Probe</p>
    <p>A 295 basepair segment of exon 3 of human beta-actin gene (nucleotides 2141-2435 as disclosed in Nakajima-lijima, S., Proc. Natl. Acad. Sci. USA 82: 6133-6137 (1985) can be amplified using 50 ul reactions that contain 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 4 mM MgCl<sub>2</sub>, 300 nM primer AFP  SEQ. I.D. No. 7!, 300 nM primer biotin-ARP  SEQ. I.D. No. 8 with biotin attached to the 5' end!, 200 Î¼M dATP, 200 Î¼M dCTP, 200 Î¼M dGTP, 200 Î¼M TTP, and 1.25 units AmpliTaq (Perkin-Elmer). The reactions are performed with (+template) or without (no template) 20 ng human genomic DNA.</p>
    <p>After thermal cycling at 50Â° C. (2 min); 95Â° C.(10 min); and 40 cycles of 95Â° C. (20 sec) followed by 60Â° C. (1 min), each sample is diluted by adding 200 Î¼l Hybridization Buffer (5Ã— SSC, 8% (v/v) formamide, 8% (v/v) Triton X-100â„¢). The resulting samples are transferred to a streptavidin-coated 96-well microtiter plate (Xenopore Corp., Saddle Brook, N.J.) and incubated at 37Â° C. for 30 min in order to capture the amplified beta-actin DNA segment. Each well is then washed with 350 Î¼l phosphate buffered saline/0.05% TWEENâ„¢-20. Any unbiotinylated DNA strands are removed by adding 100 Î¼l 0.1M NaOH/1 mM EDTA, incubating at room temperature for 5 min, and washing with 350 ul phosphate buffered saline/0.05% TWEEN-20. 50 ul of Hybridization Buffer containing 100 nM of probe A1-26  SEQ. I.D. No. 9, nucleotides 1-26 (A1-26), labeled with reporter FAM and quencher TAMRA) is then added and incubate at 37Â° C. for 30 min.</p>
    <p>Fluorescence is then measured at 518 nm and 582 nm using a Perkin-Elmer TaqMan LS-50B System. The Î”RQ is then calculated as described in Example 5. The magnitude of Î”RQ indicates the level of hybridization of the A1-26 probe and thus is a measure of the amount of amplified beta-actin DNA segment captured in each well.</p>
    <p>4. Hybridization Assay Using Oligonucleotide Probe Attached To Solid Support</p>
    <p>Three probe/solid support combinations were examined: A1-PS: A1 SEQ. I.D. No. 9! attached to polystyrene support; A1-CPG: A1  SEQ. I.D. No. 9! attached to glass support; and G1-PS: G1  SEQ. I.D. No. 13! attached to polystyrene support.</p>
    <p>All three probes have FAM attached to the 5' end of the sequence and TAMRA attached to the 3' end. No template reactions were prepared by suspending each probe/solid support sample in 50 Î¼l 1Ã— PCR Buffer (10 mM Tris-HCl (pH 8.3), 50 mM KCl, 3.5 mM MgCl<sub>2</sub>). For plus template reactions, A1-PS and A1-CPG were suspended in 50 Î¼l 1Ã— PCR Buffer +1 Î¼M A1C; G1-PS was suspended in 50 Î¼l 1Ã— PCR Buffer +1 Î¼M G1C.</p>
    <p>Reactions were incubated at 95Â° C. for 1 min, then allowed to cool slowly to room temperature. A portion of each suspension was placed on a microscope slide. Each sample was excited with 488 nm light and a fluorescence image was captured on a CCD array using either a 518 nm or 583 nm interference filter. The images were analyzed by finding a peak pixel value on the 518 nm image and then finding the 583 nm value for the same pixel. Pixel values were corrected by subtracting the background readings observed with buffer. Table 2 gives the results of fluorescence measurements of the indicated probes.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 2______________________________________518           582  no             noPROBE  temp.  +temp.  temp. +temp.                             RQ-   RQ+  Î”RQ______________________________________A1-PS  149    354     253   379   0.42  0.67 0.25A1-CPG 494    437     1500  616   1.13  2.44 1.31G1-PS   75    166     178   245   0.45  0.73 0.28______________________________________</pre>
    
    <p>5. Method For Monitoring PCR Amplification Using Oligonucleotide Probe</p>
    <p>All PCR amplifications were performed in a Perkin-Elmer Thermocycler 9600 using 50 Î¼l reactions that contained 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 200 Î¼M dATP, 200 Î¼M dCTP, 200 Î¼M dGTP, 400 Î¼M dUTP, 0.5 units AmpEraseâ„¢ uracil N-glycolyase (Perkin-Elmer), and 1.25 units AmpliTaqâ„¢ (Perkin-Elmer). A 295 basepair segment of exon 3 of human Î²-actin gene (nucleotides 2141-2435 disclosed by Nakajima-lijima, S., Proc. Natl. Acad. Sci. USA82: 6133-6137 (1985) was amplified using the AFP and ARP primers listed below. The amplification reactions contained 4 mM MgCl<sub>2</sub>, 20 ng human genomic DNA, 50 nM A1 or A3 probe, and 300 nM of each primer. Thermal regimen was 50Â° C. (2 min); 95Â° C. (10 min); 40 cycles of 95Â° C. (20 sec); 60Â° C. (1 min); and hold at 72Â° C. A 515 basepair segment was amplified from a plasmid that consists of a segment of Î» DNA (nucleotides 32, 220-32, 747) inserted into the Sma I site of vector pUC119. These reactions contained 3.5 mM MgCl<sub>2</sub>, 1 ng plasmid DNA, 50 nMP2 or P5 probe, 200 nM primer F119, and 200 nM primer R119. The thermal regimen was 50Â° C. (2 min); 95Â° C.(10 min); 25 cycles of 95Â° C.(20 sec), 57Â° C.(1 min); and hold at 72Â° C.</p>
    <p>For each amplification reaction, 40 Î¼l was transferred to an individual well of a white 96-well microtiter plate (Perkin-Elmer). Fluorescence was measured on a Perkin-Elmer TAQMANâ„¢ LS-50B System, which consists of a luminescence spectrometer with a plate reader assembly, a 485 nm excitation filter, and a 515 nm emission filter. Excitation was carried out at 488 nm using a 5 nm slit width. Emission was measured at 518 nm for 6-FAM (the reporter, or R Valve) and 582 nm for TAMRA (the quencher, or Q value) using a 10 nm slit width. In order to determine the increase in reporter emission that is due to cleavage of the probe during PCR, three normalizations are applied to the raw emission data. First, emission intensity of a buffer blank is subtracted for each wavelength. Second, emission intensity of the reporter is divided by the emission intensity of the quencher to give an RQ ratio for each reaction tube. This normalizes for well-to-well variation in probe concentration and fluorescence measurement. Finally, Î”RQ is calculated by subtracting the RQ value of the no template control (RQ<sup>-</sup>) from the RQ value for the complete reaction including a template (RQ<sup>+</sup>).</p>
    <p>Three pairs of probes were tested in PCR assays. For each pair, one probe has TAMRA attached to an internal nucleotide and the other has TAMRA attached to the 3' end nucleotide. Results are shown in Table 3. For all three sets, the probe with the 3' quencher exhibits a Î”RQ value that is considerable higher than for the probe with the internal quencher.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 3______________________________________518           582 no              noPROBE temp.   +temp.  temp. +temp.                             RQ-   RQ+  Î”RQ______________________________________A3-6  34.06   50.1    73.78 70.8  0.5   0.71 0.25A3-24 58.85   202     69.66 78.8  0.8   2.57 1.72P2-7  67.58   341     85.78 87.9  0.8   3.89 3.1P2-27 124.6   722     152.6 118   0.8   6.1  5.28P5-10 77.32   156     75.41 67    1     2.33 1.3P5-28 73.23   507     106.6 96.3  0.7   5.28 4.59______________________________________</pre>
    
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 4______________________________________Fluorescence In Single And Double-stranded States.518                  582            RQProbe  ss      ds        ss    ds     ss   ds______________________________________P2-7   63.81   84.07     96.52 142.97 0.66 0.59P2-27  92.31   557.53    165.13                          89.47  0.56 6.23P5-10  266.30  366.37    437.97                          491.00 0.61 0.75P5-28  51.91   782.80    141.20                          154.07 0.37 5.08A1-7   18.40   60.45     105.53                          218.83 0.17 0.28A1-26  87.75   734.37    90.91 118.57 0.97 6.19A3-6   44.77   104.80    90.80 177.87 0.49 0.59A3-24  45.57   857.57    100.15                          191.43 0.46 3.47______________________________________</pre>
    
    <p>Table 4 gives the results of fluorescence measurements of the indicated probes in single and double-stranded states. For probes having reporter and quencher at opposite ends of the oligonucleotide, hybridization caused a dramatic increase in RQ.</p>
    <p>The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">__________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 14(2) INFORMATION FOR SEQ ID NO: 1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 24 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:ACCCACAGGAACTGATCACCACTC24(2) INFORMATION FOR SEQ ID NO: 2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 26 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:ATGTCGCGTTCCGGCTGACGTTCTGC26(2) INFORMATION FOR SEQ ID NO: 3:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:TCGCATTACTGATCGTTGCCAACCAGT27(2) INFORMATION FOR SEQ ID NO:4:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 31 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4:GTACTGGTTGGCAACGATCAGTAATGCGATG31(2) INFORMATION FOR SEQ ID NO:5:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 28 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:CGGATTTGCTGGTATCTATGACAAGGAT28(2) INFORMATION FOR SEQ ID NO:6:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 31 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:TTCATCCTTGTCATAGATACCAGCAAATCCG31(2) INFORMATION FOR SEQ ID NO:7:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 25 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7:TCACCCACACTGTGCCCATCTACGA25(2) INFORMATION FOR SEQ ID NO:8:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 25 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:CAGCGGAACCGCTCATTGCCAATGG25(2) INFORMATION FOR SEQ ID NO:9:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 26 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:ATGCCCTCCCCCATGCCATCCTGCGT26(2) INFORMATION FOR SEQ ID NO:10:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 30 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:AGACGCAGGATGGCATGGGGGAGGGCATAC30(2) INFORMATION FOR SEQ ID NO:11:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 24 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:CGCCCTGGACTTCGAGCAAGAGAT24(2) INFORMATION FOR SEQ ID NO:12:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 28 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12:CCATCTCTTGCTCGAAGTCCAGGGCGAC28(2) INFORMATION FOR SEQ ID NO:13:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 21 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13:CAAGCTTCCCGTTCTCAGCCT21(2) INFORMATION FOR SEQ ID NO:14:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 30 nucleotides(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14:ACCGTCAAGGCTGAGAACGGGAAGCTTGTC30__________________________________________________________________________</pre>
    
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4220450">US4220450</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 5, 1978</td><td class="patent-data-table-td patent-date-value">Sep 2, 1980</td><td class="patent-data-table-td ">Syva Company</td><td class="patent-data-table-td ">Chemically induced fluorescence immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5210015">US5210015</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 6, 1990</td><td class="patent-data-table-td patent-date-value">May 11, 1993</td><td class="patent-data-table-td ">Hoffman-La Roche Inc.</td><td class="patent-data-table-td ">Polymerase chain reaction technique</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5332659">US5332659</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 15, 1993</td><td class="patent-data-table-td patent-date-value">Jul 26, 1994</td><td class="patent-data-table-td ">The United States Of America As Represented By The Secretary Of The Navy</td><td class="patent-data-table-td ">Light emission-or absorbance-based binding assays for polynucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5491063">US5491063</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 1, 1994</td><td class="patent-data-table-td patent-date-value">Feb 13, 1996</td><td class="patent-data-table-td ">Hoffmann-La Roche Inc.</td><td class="patent-data-table-td ">Methods for in-solution quenching of fluorescently labeled oligonucleotide probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0229943B1?cl=en">EP0229943B1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 1, 1986</td><td class="patent-data-table-td patent-date-value">Sep 4, 1991</td><td class="patent-data-table-td ">Molecular Biosystems, Inc.</td><td class="patent-data-table-td ">Fluorescent stokes shift probes for polynucleotide hybridization assays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0601889A2?cl=en">EP0601889A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 10, 1993</td><td class="patent-data-table-td patent-date-value">Jun 15, 1994</td><td class="patent-data-table-td ">Maine Medical Center Research Institute</td><td class="patent-data-table-td ">Nucleic acid probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=5dRJBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH05123195A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHygrazHtg2Ar726zOc-QghFnNBkg">JPH05123195A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1990003446A1?cl=en">WO1990003446A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 29, 1989</td><td class="patent-data-table-td patent-date-value">Apr 5, 1990</td><td class="patent-data-table-td ">New York Health Res Inst</td><td class="patent-data-table-td ">Nucleic acid probes containing improved molecular switch, and assays and kits incorporating same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1992002638A1?cl=en">WO1992002638A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 6, 1991</td><td class="patent-data-table-td patent-date-value">Feb 7, 1992</td><td class="patent-data-table-td ">Cetus Corp</td><td class="patent-data-table-td ">Homogeneous assay system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993013224A1?cl=en">WO1993013224A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 22, 1992</td><td class="patent-data-table-td patent-date-value">Jul 8, 1993</td><td class="patent-data-table-td ">Chiron Corp</td><td class="patent-data-table-td ">Process for immobilizing nucleic acid probes on polystyrene surfaces</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Cardullo et al., "<a href='http://scholar.google.com/scholar?q="Detection+of+nucleic+acid+hybridization+by+nonradiative+fluorescence+resonance+energy+transfer"'>Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer</a>", Proc. Natl. Acad. Sci., 85: 8790-8794 (1988).</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Cardullo et al., Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer , Proc. Natl. Acad. Sci., 85: 8790 8794 (1988).</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Clegg et al., "<a href='http://scholar.google.com/scholar?q="Observing+the+helical+geometry+of+double-stranded+DNA+in+solution+by+fluorescene+resonance+energy+transfer"'>Observing the helical geometry of double-stranded DNA in solution by fluorescene resonance energy transfer</a>", Proc. Natl. Acad. Sci., 90: 2994-2998 (1993).</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Clegg et al., Observing the helical geometry of double stranded DNA in solution by fluorescene resonance energy transfer , Proc. Natl. Acad. Sci., 90: 2994 2998 (1993).</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Clegg, "<a href='http://scholar.google.com/scholar?q="Fluorescence+resonance+energy+transfer+and+nucleic+acids%2C"'>Fluorescence resonance energy transfer and nucleic acids,</a>" Methods of Enzymology, 211: 353-389 (1992).</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Clegg, Fluorescence resonance energy transfer and nucleic acids, Methods of Enzymology, 211: 353 389 (1992).</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Heller et al., "<a href='http://scholar.google.com/scholar?q="Fluorescent+energy+transfer+oligonucleotide+probes"'>Fluorescent energy transfer oligonucleotide probes</a>", Abstract 248, Fed. Proc., 46: 1968 (1987).</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Heller et al., Fluorescent energy transfer oligonucleotide probes , Abstract 248, Fed. Proc., 46: 1968 (1987).</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Higuchi et al., "<a href='http://scholar.google.com/scholar?q="Kinetic+PCR+analysis%3A+real-time+monitoring+of+DNA+amplification+reactions%2C"'>Kinetic PCR analysis: real-time monitoring of DNA amplification reactions,</a>" Biotechnology, 11:1026-1030 (1993).</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Higuchi et al., "<a href='http://scholar.google.com/scholar?q="Simultaneous+amplification+and+detection+of+specific+DNA+sequences"'>Simultaneous amplification and detection of specific DNA sequences</a>", Biotechnology, 10:413-417 (1992).</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Higuchi et al., Kinetic PCR analysis: real time monitoring of DNA amplification reactions, Biotechnology, 11:1026 1030 (1993).</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Higuchi et al., Simultaneous amplification and detection of specific DNA sequences , Biotechnology, 10:413 417 (1992).</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Holland et al., Detection of specific polymerase chain reaction product by utilizing the 5 3 exonuclease activity of the Thermus acquaticus DNA polymerase , Proc. Natl. Acad. Sci., 88: 7276 7280 (1991).</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Holland et al., Detection of specific polymerase chain reaction product by utilizing the 5'<a href='http://scholar.google.com/scholar?q="%E2%86%923"'>â†’3</a>' exonuclease activity of the Thermus acquaticus DNA polymerase , Proc. Natl. Acad. Sci., 88: 7276-7280 (1991).</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Jean Louis Mergny et al., Fluorescence Energy Transfer as a Probe for Nucleic Acid Structures and Sequences, Nucleic Acids Research, 1994, vol. 22, No. 6.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Jean-Louis Mergny et al., "<a href='http://scholar.google.com/scholar?q="Fluorescence+Energy+Transfer+as+a+Probe+for+Nucleic+Acid+Structures+and+Sequences%2C"'>Fluorescence Energy Transfer as a Probe for Nucleic Acid Structures and Sequences,</a>" Nucleic Acids Research, 1994, vol. 22, No. 6.</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">K. J. Livak et al., Oligonucleotides with Fluoresc. Dyes at Opp. Ends Provide a Quenched Probe System Useful for Detecting PCR Prod. and Nucleic Acid Hybrid., PCR Methods and Applications, pp. 357 362, 1994.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">K. J. Livak et al., Oligonucleotides with Fluoresc. Dyes at Opp. Ends Provide a Quenched Probe System Useful for Detecting PCR Prod. and Nucleic Acid Hybrid., PCR Methods and Applications, pp. 357-362, 1994.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lee et al., "<a href='http://scholar.google.com/scholar?q="Allelic+discrimination+by+nick-translation+PCR+with+fluorogenic+probes%2C"'>Allelic discrimination by nick-translation PCR with fluorogenic probes,</a>" Nucleic Acids Research, 21: 3761-3766 (1993).</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Lee et al., Allelic discrimination by nick translation PCR with fluorogenic probes, Nucleic Acids Research, 21: 3761 3766 (1993).</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ozaki et al., "<a href='http://scholar.google.com/scholar?q="The+estimation+of+distances+between+specific+backbone-labeled+sites+in+DNA+using+fluorescence+resonance+energy+transfer%2C"'>The estimation of distances between specific backbone-labeled sites in DNA using fluorescence resonance energy transfer,</a>" Nucleic Acids Research, 20: 5205-5214 (1992).</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ozaki et al., The estimation of distances between specific backbone labeled sites in DNA using fluorescence resonance energy transfer, Nucleic Acids Research, 20: 5205 5214 (1992).</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Parkhurst, et al. "<a href='http://scholar.google.com/scholar?q="Kinetic+Studies+by+Fluorescence+Resonance+Energy+Transfer+Employing+a+Double-Labeled+Oligonucleotide%3A+Hybridization+to+the+Oligonucleotide+Complement+and+to+Single-Stranded+DNA"'>Kinetic Studies by Fluorescence Resonance Energy Transfer Employing a Double-Labeled Oligonucleotide: Hybridization to the Oligonucleotide Complement and to Single-Stranded DNA</a>", Biochemistry, 34, 285-292 (1995).</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Parkhurst, et al. Kinetic Studies by Fluorescence Resonance Energy Transfer Employing a Double Labeled Oligonucleotide: Hybridization to the Oligonucleotide Complement and to Single Stranded DNA , Biochemistry, 34, 285 292 (1995).</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Roche Inventor Disclosure (disclosed to Applied Biosystems prior to Nov. 1994).</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">S. Tyagi et al., Molecular Beacons: Probes that Fluoresce upon Hybrodization, Dept. of Molecular Genetics, Public Health Research Institute, New York, N. Y., 1994.</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stryer et al., "<a href='http://scholar.google.com/scholar?q="Energy+transfer%3A+a+spectroscopic+ruler"'>Energy transfer: a spectroscopic ruler</a>", Proc. Natl. Acad. Sci., 58: 719-726 (1967).</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Stryer et al., Energy transfer: a spectroscopic ruler , Proc. Natl. Acad. Sci., 58: 719 726 (1967).</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wu et al., "<a href='http://scholar.google.com/scholar?q="Resonance+energy+transfer%3A+methods+and+applications%2C"'>Resonance energy transfer: methods and applications,</a>" Anal. Biochem., 218: 1-13 (1994).</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Wu et al., Resonance energy transfer: methods and applications, Anal. Biochem., 218: 1 13 (1994).</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Z. Guo et al., "<a href='http://scholar.google.com/scholar?q="Direct+Fluoresc.+Analysis+of+Genetic+Polymorph.+by+Hybrid.+with+Oligonucleptide+Arrays+on+Glass+Suports"'>Direct Fluoresc. Analysis of Genetic Polymorph. by Hybrid. with Oligonucleptide Arrays on Glass Suports</a>", Nucleic Acids Research, 1994, vol. 22, No. 24.</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Z. Guo et al., Direct Fluoresc. Analysis of Genetic Polymorph. by Hybrid. with Oligonucleptide Arrays on Glass Suports , Nucleic Acids Research, 1994, vol. 22, No. 24.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6030787">US6030787</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 7, 1998</td><td class="patent-data-table-td patent-date-value">Feb 29, 2000</td><td class="patent-data-table-td ">Pe Corporation</td><td class="patent-data-table-td ">Hybridization assay using self-quenching fluorescence probe</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6180349">US6180349</a></td><td class="patent-data-table-td patent-date-value">May 18, 1999</td><td class="patent-data-table-td patent-date-value">Jan 30, 2001</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Quantitative PCR method to enumerate DNA copy number</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6235480">US6235480</a></td><td class="patent-data-table-td patent-date-value">Jul 21, 1999</td><td class="patent-data-table-td patent-date-value">May 22, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Screening for the presence of target nucleotide sequences; incubate preferential nucleotide sequences with enzymes and screen for preferentially released nucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6248518">US6248518</a></td><td class="patent-data-table-td patent-date-value">Oct 28, 1997</td><td class="patent-data-table-td patent-date-value">Jun 19, 2001</td><td class="patent-data-table-td ">Board Of Regents Of University Of Nebraska</td><td class="patent-data-table-td ">Attaching dyes to probe, hybridizing to dna sequence, recording value of emissions, heating, monitoring temperature at which emissions are reduced, and determining observed melting point; reduced melting point indicates mutation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6258569">US6258569</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 8, 1999</td><td class="patent-data-table-td patent-date-value">Jul 10, 2001</td><td class="patent-data-table-td ">The Perkin-Elmer Corporation</td><td class="patent-data-table-td ">Amplifying using polymerase with 5&#39; to 3&#39; nuclease activity, a primer, and an oligonucleotide probe with fluorescent reporter and quencher attached at opposite ends; digestion of probe by polymerase increases signal</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6268146">US6268146</a></td><td class="patent-data-table-td patent-date-value">Oct 22, 1999</td><td class="patent-data-table-td patent-date-value">Jul 31, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Analytical methods and materials for nucleic acid detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6270973">US6270973</a></td><td class="patent-data-table-td patent-date-value">Sep 27, 1999</td><td class="patent-data-table-td patent-date-value">Aug 7, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Monitoring nucleotide sequences in a sample; mix nucleotide sequences and probes, mix sample with a depolymerizing enzyme, incubate, analyze sample for preferential sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6270974">US6270974</a></td><td class="patent-data-table-td patent-date-value">Sep 27, 1999</td><td class="patent-data-table-td patent-date-value">Aug 7, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Exogenous nucleic acid detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6277578">US6277578</a></td><td class="patent-data-table-td patent-date-value">Oct 29, 1999</td><td class="patent-data-table-td patent-date-value">Aug 21, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Deploymerization method for nucleic acid detection of an amplified nucleic acid target</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6312902">US6312902</a></td><td class="patent-data-table-td patent-date-value">Sep 27, 1999</td><td class="patent-data-table-td patent-date-value">Nov 6, 2001</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Nucleic acid detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6326145">US6326145</a></td><td class="patent-data-table-td patent-date-value">Nov 25, 1998</td><td class="patent-data-table-td patent-date-value">Dec 4, 2001</td><td class="patent-data-table-td ">Zeneca Limited</td><td class="patent-data-table-td ">Methods for detecting target nucleic acid sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6355433">US6355433</a></td><td class="patent-data-table-td patent-date-value">Jun 2, 2000</td><td class="patent-data-table-td patent-date-value">Mar 12, 2002</td><td class="patent-data-table-td ">Dna Sciences, Inc.</td><td class="patent-data-table-td ">Analyzing variant sites of target nucleic acid by extending primers in the presence of a nucleic acid and a mixture of labeled extendible/nonextendible nucleotides that are complementary to variant allelic sites on target nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6387652">US6387652</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 2000</td><td class="patent-data-table-td patent-date-value">May 14, 2002</td><td class="patent-data-table-td ">U.S. Environmental Protection Agency</td><td class="patent-data-table-td ">Extracting and recovering dna from organism in sample, then hybridizing and amplifying dna sequences; detection without interference of other dna</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6391551">US6391551</a></td><td class="patent-data-table-td patent-date-value">Aug 25, 1999</td><td class="patent-data-table-td patent-date-value">May 21, 2002</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Simple, automatable method of determining presence of endogenous target sequence in sample by mixing target sequence hybridized with 3&#39;-labeled probe with enzyme that releases nucleotides from 3&#39;-end, and analyzing for label</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6418383">US6418383</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 11, 2000</td><td class="patent-data-table-td patent-date-value">Jul 9, 2002</td><td class="patent-data-table-td ">Perkinelmer Instruments Llc</td><td class="patent-data-table-td ">Method and apparatus for iterative spectral compensation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6448015">US6448015</a></td><td class="patent-data-table-td patent-date-value">Apr 23, 2001</td><td class="patent-data-table-td patent-date-value">Sep 10, 2002</td><td class="patent-data-table-td ">Board Of Regents Of University Of Nebraska</td><td class="patent-data-table-td ">Probe for detecting point mutations in DNA utilizing fluorescence energy transfer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6458544">US6458544</a></td><td class="patent-data-table-td patent-date-value">Dec 1, 2000</td><td class="patent-data-table-td patent-date-value">Oct 1, 2002</td><td class="patent-data-table-td ">Dna Sciences, Inc.</td><td class="patent-data-table-td ">Methods for determining single nucleotide variations and genotyping</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6485901">US6485901</a></td><td class="patent-data-table-td patent-date-value">Oct 26, 1998</td><td class="patent-data-table-td patent-date-value">Nov 26, 2002</td><td class="patent-data-table-td ">Boston Probes, Inc.</td><td class="patent-data-table-td ">Methods, kits and compositions pertaining to linear beacons</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6485903">US6485903</a></td><td class="patent-data-table-td patent-date-value">Apr 3, 1997</td><td class="patent-data-table-td patent-date-value">Nov 26, 2002</td><td class="patent-data-table-td ">Pe Corporation (Ny)</td><td class="patent-data-table-td ">Methods and reagents for combined PCR amplification and hybridization probing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6500650">US6500650</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 5, 2000</td><td class="patent-data-table-td patent-date-value">Dec 31, 2002</td><td class="patent-data-table-td ">Variagenics, Inc.</td><td class="patent-data-table-td ">Method for identifying polymorphisms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6573047">US6573047</a></td><td class="patent-data-table-td patent-date-value">Apr 11, 2000</td><td class="patent-data-table-td patent-date-value">Jun 3, 2003</td><td class="patent-data-table-td ">Dna Sciences, Inc.</td><td class="patent-data-table-td ">Detection of nucleotide sequence variation through fluorescence resonance energy transfer label generation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6627400">US6627400</a></td><td class="patent-data-table-td patent-date-value">Oct 27, 2000</td><td class="patent-data-table-td patent-date-value">Sep 30, 2003</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Contacting a binding compound having reporters molecules with a sample; cleaving; electrophoretically separating and identifying the released reporter molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6635428">US6635428</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 2001</td><td class="patent-data-table-td patent-date-value">Oct 21, 2003</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Oligonucleotides and methods for detecting hepatitis B viral nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6649349">US6649349</a></td><td class="patent-data-table-td patent-date-value">Sep 10, 2001</td><td class="patent-data-table-td patent-date-value">Nov 18, 2003</td><td class="patent-data-table-td ">Boston Probes, Inc.</td><td class="patent-data-table-td ">Peptide nucleic acid for use in the diagnosis, detection and prevention of blood, respiratory and cancer disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6653078">US6653078</a></td><td class="patent-data-table-td patent-date-value">Feb 20, 2001</td><td class="patent-data-table-td patent-date-value">Nov 25, 2003</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Multiplex method for nucleic acid detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6653473">US6653473</a></td><td class="patent-data-table-td patent-date-value">Feb 26, 2002</td><td class="patent-data-table-td patent-date-value">Nov 25, 2003</td><td class="patent-data-table-td ">Epoch Biosciences, Inc.</td><td class="patent-data-table-td ">Fluorescent quenching detection reagents and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6673550">US6673550</a></td><td class="patent-data-table-td patent-date-value">Nov 9, 2001</td><td class="patent-data-table-td patent-date-value">Jan 6, 2004</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Probes for use in the detection and measurement of preferential compound in sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6686152">US6686152</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2001</td><td class="patent-data-table-td patent-date-value">Feb 3, 2004</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Methods employing oligonucleotide-binding e-tag probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6699975">US6699975</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2002</td><td class="patent-data-table-td patent-date-value">Mar 2, 2004</td><td class="patent-data-table-td ">Epoch Biosciences, Inc.</td><td class="patent-data-table-td ">Fluorescent quenching detection reagents and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6703211">US6703211</a></td><td class="patent-data-table-td patent-date-value">Sep 15, 1999</td><td class="patent-data-table-td patent-date-value">Mar 9, 2004</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Cellular detection by providing high energy phosphate donor other than ADP to produce ATP</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6730479">US6730479</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td patent-date-value">May 4, 2004</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Detection of nucleic acid hybrids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6790945">US6790945</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 2001</td><td class="patent-data-table-td patent-date-value">Sep 14, 2004</td><td class="patent-data-table-td ">Epoch Biosciences, Inc.</td><td class="patent-data-table-td ">Fluorescent quenching detection reagents and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6811973">US6811973</a></td><td class="patent-data-table-td patent-date-value">Nov 23, 2000</td><td class="patent-data-table-td patent-date-value">Nov 2, 2004</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Methods of using labeled probe molecules to quantify target molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6818399">US6818399</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2001</td><td class="patent-data-table-td patent-date-value">Nov 16, 2004</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Electrophoretic tag (e-tag) probes; detection involves the release of identifying tags as a consequence of target recognition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6821727">US6821727</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 28, 2000</td><td class="patent-data-table-td patent-date-value">Nov 23, 2004</td><td class="patent-data-table-td ">Applera Corporation</td><td class="patent-data-table-td ">Used for genetic replication/polymerase chain reaction (pcr); solid phase synthesis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6825009">US6825009</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 22, 2002</td><td class="patent-data-table-td patent-date-value">Nov 30, 2004</td><td class="patent-data-table-td ">Variagenics, Inc.</td><td class="patent-data-table-td ">Method for identifying polymorphisms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6830902">US6830902</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2000</td><td class="patent-data-table-td patent-date-value">Dec 14, 2004</td><td class="patent-data-table-td ">Invitrogen Corporation</td><td class="patent-data-table-td ">Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6861515">US6861515</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td patent-date-value">Mar 1, 2005</td><td class="patent-data-table-td ">Commissariat A L&#39;energie Atomique</td><td class="patent-data-table-td ">Analysis of biological targets using a biochip comprising a fluorescent marker</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6884583">US6884583</a></td><td class="patent-data-table-td patent-date-value">Mar 21, 2002</td><td class="patent-data-table-td patent-date-value">Apr 26, 2005</td><td class="patent-data-table-td ">Applera Corporation</td><td class="patent-data-table-td ">Detecting preferential nucleotide sequences in sample; obtain nucleotide sequence sample, incubate with primers and probes, amplify nucleotide sequences, detect hybridization signal from probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6916612">US6916612</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2001</td><td class="patent-data-table-td patent-date-value">Jul 12, 2005</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Sets of oligonucleotide-binding e-tag probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6936442">US6936442</a></td><td class="patent-data-table-td patent-date-value">Jun 28, 2002</td><td class="patent-data-table-td patent-date-value">Aug 30, 2005</td><td class="patent-data-table-td ">Chiron Corporation</td><td class="patent-data-table-td ">Amplification; genetic engineering</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6946245">US6946245</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 2001</td><td class="patent-data-table-td patent-date-value">Sep 20, 2005</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Oligonucleotides and methods for detecting hepatitis C viral nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6955874">US6955874</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2001</td><td class="patent-data-table-td patent-date-value">Oct 18, 2005</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Kits employing oligonucleotide-binding e-tag probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7001725">US7001725</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2001</td><td class="patent-data-table-td patent-date-value">Feb 21, 2006</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Assay for the detection of preferential particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7037654">US7037654</a></td><td class="patent-data-table-td patent-date-value">Nov 9, 2001</td><td class="patent-data-table-td patent-date-value">May 2, 2006</td><td class="patent-data-table-td ">Aclara Biosciences, Inc.</td><td class="patent-data-table-td ">Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7041459">US7041459</a></td><td class="patent-data-table-td patent-date-value">May 21, 2002</td><td class="patent-data-table-td patent-date-value">May 9, 2006</td><td class="patent-data-table-td ">Monogram Biosciences, Inc.</td><td class="patent-data-table-td ">Analyzing phosphorylated proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7081336">US7081336</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2002</td><td class="patent-data-table-td patent-date-value">Jul 25, 2006</td><td class="patent-data-table-td ">Georgia Tech Research Corporation</td><td class="patent-data-table-td ">Dual resonance energy transfer nucleic acid probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7090975">US7090975</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 2001</td><td class="patent-data-table-td patent-date-value">Aug 15, 2006</td><td class="patent-data-table-td ">Promega Corporation</td><td class="patent-data-table-td ">Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7112404">US7112404</a></td><td class="patent-data-table-td patent-date-value">Dec 10, 2001</td><td class="patent-data-table-td patent-date-value">Sep 26, 2006</td><td class="patent-data-table-td ">Epigenomics Ag</td><td class="patent-data-table-td ">Process for high throughput DNA methylation analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7132239">US7132239</a></td><td class="patent-data-table-td patent-date-value">Jun 4, 2003</td><td class="patent-data-table-td patent-date-value">Nov 7, 2006</td><td class="patent-data-table-td ">Applera Corporation</td><td class="patent-data-table-td ">Determination of a genotype of an amplification product at multiple allelic sites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7160735">US7160735</a></td><td class="patent-data-table-td patent-date-value">Nov 8, 2002</td><td class="patent-data-table-td patent-date-value">Jan 9, 2007</td><td class="patent-data-table-td ">Monogram Biosciences, Inc.</td><td class="patent-data-table-td ">Tagged microparticle compositions and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7232807">US7232807</a></td><td class="patent-data-table-td patent-date-value">Apr 22, 2005</td><td class="patent-data-table-td patent-date-value">Jun 19, 2007</td><td class="patent-data-table-td ">Oligomerix, Inc.</td><td class="patent-data-table-td ">An RNA molecule having a sequence portion that has affinity to at least one consensus sequence present in an agglomeration nucleic acid-binding protein; detection of affinity complex formed confirms diagnoses of diseases such as spongiform encephalopathies</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7241596">US7241596</a></td><td class="patent-data-table-td patent-date-value">Sep 20, 2004</td><td class="patent-data-table-td patent-date-value">Jul 10, 2007</td><td class="patent-data-table-td ">Applera Corporation</td><td class="patent-data-table-td ">Methods and reagents for combined PCR amplification and hybridization probing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7250506">US7250506</a></td><td class="patent-data-table-td patent-date-value">Jan 16, 2004</td><td class="patent-data-table-td patent-date-value">Jul 31, 2007</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Conjugated nucleotides to a detectable fluorescent dye; trancribing primers/probes for replication; qualitative and quantitative analysis of detecting viral nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7255999">US7255999</a></td><td class="patent-data-table-td patent-date-value">May 21, 2002</td><td class="patent-data-table-td patent-date-value">Aug 14, 2007</td><td class="patent-data-table-td ">Monogram Biosciences, Inc.</td><td class="patent-data-table-td ">Methods and compositions for analyzing proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7262292">US7262292</a></td><td class="patent-data-table-td patent-date-value">Oct 20, 2003</td><td class="patent-data-table-td patent-date-value">Aug 28, 2007</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Oligonucleotides and methods for detecting hepatitis B viral nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7291459">US7291459</a></td><td class="patent-data-table-td patent-date-value">Dec 10, 2002</td><td class="patent-data-table-td patent-date-value">Nov 6, 2007</td><td class="patent-data-table-td ">University Of Alabama At Huntsville</td><td class="patent-data-table-td ">Nucleic acid detector and method of detecting targets within a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7297494">US7297494</a></td><td class="patent-data-table-td patent-date-value">Jan 21, 2005</td><td class="patent-data-table-td patent-date-value">Nov 20, 2007</td><td class="patent-data-table-td ">Georgia Tech Research Corporation</td><td class="patent-data-table-td ">Activatable probes and methods for in vivo gene detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7358052">US7358052</a></td><td class="patent-data-table-td patent-date-value">May 24, 2002</td><td class="patent-data-table-td patent-date-value">Apr 15, 2008</td><td class="patent-data-table-td ">Monogram Biosciences, Inc.</td><td class="patent-data-table-td ">Detection of preferential particles in sample; obtain sample, incubate with binding agent, expose to electric field and probes, detect signal</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7381818">US7381818</a></td><td class="patent-data-table-td patent-date-value">Oct 27, 2004</td><td class="patent-data-table-td patent-date-value">Jun 3, 2008</td><td class="patent-data-table-td ">Epoch Biosciences, Inc.</td><td class="patent-data-table-td ">Fluorescent probes containing 5â€²-minor groove binder, fluorophore and quenching moieties and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7399591">US7399591</a></td><td class="patent-data-table-td patent-date-value">Feb 2, 2006</td><td class="patent-data-table-td patent-date-value">Jul 15, 2008</td><td class="patent-data-table-td ">Georgia Tech Research Corporation</td><td class="patent-data-table-td ">Provided on hairpin stem- loop molecular beacon probes that hybridize sufficiently near each other on a subject nucleic acid, e.g. mRNA, to generate an observable interaction; lanthanide chelate luminescent resonance energy transfer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7413708">US7413708</a></td><td class="patent-data-table-td patent-date-value">Jul 9, 2007</td><td class="patent-data-table-td patent-date-value">Aug 19, 2008</td><td class="patent-data-table-td ">Applied Biosystems Inc.</td><td class="patent-data-table-td ">Methods and reagents for combined PCR amplification</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7422852">US7422852</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2003</td><td class="patent-data-table-td patent-date-value">Sep 9, 2008</td><td class="patent-data-table-td ">Boston Probes, Inc.</td><td class="patent-data-table-td ">Peptide nucleic acid for use in the diagnosis, detection and prevention of blood, respiratory and cancer disorders; contacting the sample with a Linear Beacon and then detecting, identifying or quantitating the change in detectable signal associated with at least one donor or acceptor moiety of the probe</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7476735">US7476735</a></td><td class="patent-data-table-td patent-date-value">May 22, 2006</td><td class="patent-data-table-td patent-date-value">Jan 13, 2009</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Compounds and methods for labeling oligonucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7527962">US7527962</a></td><td class="patent-data-table-td patent-date-value">Dec 7, 2005</td><td class="patent-data-table-td patent-date-value">May 5, 2009</td><td class="patent-data-table-td ">Millenium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Nucleic acid which encode diacylglycerol acyltransferase family members; obesity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7537886">US7537886</a></td><td class="patent-data-table-td patent-date-value">Jun 22, 2000</td><td class="patent-data-table-td patent-date-value">May 26, 2009</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Primers and methods for the detection and discrimination of nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7537938">US7537938</a></td><td class="patent-data-table-td patent-date-value">Jan 26, 2004</td><td class="patent-data-table-td patent-date-value">May 26, 2009</td><td class="patent-data-table-td ">Monogram Biosciences, Inc.</td><td class="patent-data-table-td ">metastasized from a solid tumor; for quantification of protein-protein complexes for diagnosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7553627">US7553627</a></td><td class="patent-data-table-td patent-date-value">Sep 8, 2006</td><td class="patent-data-table-td patent-date-value">Jun 30, 2009</td><td class="patent-data-table-td ">University of Southern California, USC Stevens Center for Innovation</td><td class="patent-data-table-td ">Detecting cytosine methylation and methylated cytosine/guanine aggregations; incubate genomic nucleotide sequences adjusting agent, amplify nucleotide sequences, detecting the methylated nucleotide sequences</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7565250">US7565250</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 2004</td><td class="patent-data-table-td patent-date-value">Jul 21, 2009</td><td class="patent-data-table-td ">Abbott Laboratories Inc.</td><td class="patent-data-table-td ">Method and system for analyzing reactions using an information system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7575863">US7575863</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 2004</td><td class="patent-data-table-td patent-date-value">Aug 18, 2009</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Methods, compositions, and kits comprising linker probes for quantifying polynucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7601495">US7601495</a></td><td class="patent-data-table-td patent-date-value">May 31, 2005</td><td class="patent-data-table-td patent-date-value">Oct 13, 2009</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">MicroRNA; peptide nucleic acids; locked nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7605243">US7605243</a></td><td class="patent-data-table-td patent-date-value">Jan 12, 2009</td><td class="patent-data-table-td patent-date-value">Oct 20, 2009</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">With reporter moieties including azo quenchers, fluorophores, biotin, digoxigenin, peptides and proteins; kits</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7642055">US7642055</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 2005</td><td class="patent-data-table-td patent-date-value">Jan 5, 2010</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Quantifying a small target polyncucleotide; a pair of linker probes can be employed in two different reactions to query a particular species of target polynucleotide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7645872">US7645872</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 2009</td><td class="patent-data-table-td patent-date-value">Jan 12, 2010</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Compounds and methods for labeling oligonucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7759126">US7759126</a></td><td class="patent-data-table-td patent-date-value">Mar 12, 2008</td><td class="patent-data-table-td patent-date-value">Jul 20, 2010</td><td class="patent-data-table-td ">Elitech Holding B.V.</td><td class="patent-data-table-td ">Real-time linear detection probes: sensitive 5â€²-minor groove binder-containing probes for amplification (or PCR) analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7771929">US7771929</a></td><td class="patent-data-table-td patent-date-value">Apr 18, 2003</td><td class="patent-data-table-td patent-date-value">Aug 10, 2010</td><td class="patent-data-table-td ">Monogram Biosciences, Inc.</td><td class="patent-data-table-td ">Labeled oligonucleotides; immobilization to polymer; binding to target compound; detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7803936">US7803936</a></td><td class="patent-data-table-td patent-date-value">Nov 23, 2009</td><td class="patent-data-table-td patent-date-value">Sep 28, 2010</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Compounds and methods for labeling oligonucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7811561">US7811561</a></td><td class="patent-data-table-td patent-date-value">Nov 10, 2000</td><td class="patent-data-table-td patent-date-value">Oct 12, 2010</td><td class="patent-data-table-td ">Gartenhaus Ronald B</td><td class="patent-data-table-td ">MCT-1, a human oncogene</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7824858">US7824858</a></td><td class="patent-data-table-td patent-date-value">Jan 23, 2006</td><td class="patent-data-table-td patent-date-value">Nov 2, 2010</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">determining the presence of Mycobacterium avium complex nucleic acids in a biological sample by detecting the mig gene of M. avium and the DT1 gene of M. intracellulare and amplifying them</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7847076">US7847076</a></td><td class="patent-data-table-td patent-date-value">Aug 18, 2008</td><td class="patent-data-table-td patent-date-value">Dec 7, 2010</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">combined amplification and hybridization probe detection of amplified nucleic acid target sequence in a single reaction vessel using a single reagent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7892741">US7892741</a></td><td class="patent-data-table-td patent-date-value">Sep 8, 2008</td><td class="patent-data-table-td patent-date-value">Feb 22, 2011</td><td class="patent-data-table-td ">Boston Probes, Inc.</td><td class="patent-data-table-td ">Methods, kits and compositions pertaining to linear beacons</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7897736">US7897736</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2010</td><td class="patent-data-table-td patent-date-value">Mar 1, 2011</td><td class="patent-data-table-td ">Elitech Holding B.V.</td><td class="patent-data-table-td ">Fluorescent quenching detecting reagents and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7910346">US7910346</a></td><td class="patent-data-table-td patent-date-value">Feb 17, 2009</td><td class="patent-data-table-td patent-date-value">Mar 22, 2011</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7972778">US7972778</a></td><td class="patent-data-table-td patent-date-value">Mar 11, 2004</td><td class="patent-data-table-td patent-date-value">Jul 5, 2011</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Using multicompartment apparatus for replicating nucleotide sequences on a miniaturized scale; fertility, immunology, cytology and pharmaceutical screening</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8005625">US8005625</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 2008</td><td class="patent-data-table-td patent-date-value">Aug 23, 2011</td><td class="patent-data-table-td ">Abbott Laboratories, Inc.</td><td class="patent-data-table-td ">Method for analyzing reactions using an information system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8030460">US8030460</a></td><td class="patent-data-table-td patent-date-value">Aug 10, 2010</td><td class="patent-data-table-td patent-date-value">Oct 4, 2011</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Compounds and methods for labeling oligonucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8043816">US8043816</a></td><td class="patent-data-table-td patent-date-value">May 18, 2009</td><td class="patent-data-table-td patent-date-value">Oct 25, 2011</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Compositions and methods for temperature-dependent nucleic acid synthesis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8067159">US8067159</a></td><td class="patent-data-table-td patent-date-value">Aug 13, 2007</td><td class="patent-data-table-td patent-date-value">Nov 29, 2011</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Microfluidics; electromagnetics; electrophoresis; DNA sequence analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084212">US8084212</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 2010</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Assay for Mycobacterium avium/intracellulare nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084588">US8084588</a></td><td class="patent-data-table-td patent-date-value">Oct 16, 2008</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Fluorescence quenching azo dyes, their methods of preparation and use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8088572">US8088572</a></td><td class="patent-data-table-td patent-date-value">May 20, 2005</td><td class="patent-data-table-td patent-date-value">Jan 3, 2012</td><td class="patent-data-table-td ">Aes Chemunex S.A.</td><td class="patent-data-table-td ">Polynucleotides for the detection of Escherichia coli O157:H7 and Escherichia coli O157:NM verotoxin producers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8099243">US8099243</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 2008</td><td class="patent-data-table-td patent-date-value">Jan 17, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Methods for quantifying a concentration of a target nucleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8114979">US8114979</a></td><td class="patent-data-table-td patent-date-value">Aug 10, 2010</td><td class="patent-data-table-td patent-date-value">Feb 14, 2012</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Di-alpha amino anthraquinone compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8257925">US8257925</a></td><td class="patent-data-table-td patent-date-value">May 16, 2011</td><td class="patent-data-table-td patent-date-value">Sep 4, 2012</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Method for detecting the presence of a single target nucleic acid in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8258276">US8258276</a></td><td class="patent-data-table-td patent-date-value">Sep 2, 2011</td><td class="patent-data-table-td patent-date-value">Sep 4, 2012</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Compounds and methods for labeling oligonucleotides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8263330">US8263330</a></td><td class="patent-data-table-td patent-date-value">Mar 8, 2005</td><td class="patent-data-table-td patent-date-value">Sep 11, 2012</td><td class="patent-data-table-td ">Quest Diagnostics Investments Incorporated</td><td class="patent-data-table-td ">Detection of Mycobacterium tuberculosis complex nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8278071">US8278071</a></td><td class="patent-data-table-td patent-date-value">Aug 13, 2007</td><td class="patent-data-table-td patent-date-value">Oct 2, 2012</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Method for detecting the presence of a single target nucleic acid in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8323890">US8323890</a></td><td class="patent-data-table-td patent-date-value">Jun 2, 2009</td><td class="patent-data-table-td patent-date-value">Dec 4, 2012</td><td class="patent-data-table-td ">The University Of Southern California</td><td class="patent-data-table-td ">Process for high-throughput DNA methylation analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8334111">US8334111</a></td><td class="patent-data-table-td patent-date-value">Jan 28, 2011</td><td class="patent-data-table-td patent-date-value">Dec 18, 2012</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8377641">US8377641</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 2011</td><td class="patent-data-table-td patent-date-value">Feb 19, 2013</td><td class="patent-data-table-td ">Integrated Dna Technologies, Inc.</td><td class="patent-data-table-td ">Fluorescence quenching azo dyes, their methods of preparation and use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394609">US8394609</a></td><td class="patent-data-table-td patent-date-value">Dec 1, 2009</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Primers and methods for the detection and discrimination of nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8426132">US8426132</a></td><td class="patent-data-table-td patent-date-value">Nov 3, 2008</td><td class="patent-data-table-td patent-date-value">Apr 23, 2013</td><td class="patent-data-table-td ">Bio-Rad Laboratories, Inc.</td><td class="patent-data-table-td ">Quantitative amplification with a labeled probe and 3â€² to 5â€² exonuclease activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8551698">US8551698</a></td><td class="patent-data-table-td patent-date-value">Aug 13, 2007</td><td class="patent-data-table-td patent-date-value">Oct 8, 2013</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Method of loading sample into a microfluidic device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8563275">US8563275</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 2012</td><td class="patent-data-table-td patent-date-value">Oct 22, 2013</td><td class="patent-data-table-td ">Applied Biosystems, Llc</td><td class="patent-data-table-td ">Method and device for detecting the presence of a single target nucleic acid in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8658776">US8658776</a></td><td class="patent-data-table-td patent-date-value">May 26, 2011</td><td class="patent-data-table-td patent-date-value">Feb 25, 2014</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Synthesis of 2â€²,3â€²-dideoxynucleosides for automated DNA synthesis and pyrophosphorolysis activated polymerization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8679789">US8679789</a></td><td class="patent-data-table-td patent-date-value">Apr 30, 2004</td><td class="patent-data-table-td patent-date-value">Mar 25, 2014</td><td class="patent-data-table-td ">Gen-Probe Incorporated</td><td class="patent-data-table-td ">Oligonucleotides comprising a molecular switch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8680254">US8680254</a></td><td class="patent-data-table-td patent-date-value">Jan 14, 2010</td><td class="patent-data-table-td patent-date-value">Mar 25, 2014</td><td class="patent-data-table-td ">Philadelphia Health &amp; Education Corporation</td><td class="patent-data-table-td ">Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8748092">US8748092</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 12, 2011</td><td class="patent-data-table-td patent-date-value">Jun 10, 2014</td><td class="patent-data-table-td ">Focus Diagnostics, Inc.</td><td class="patent-data-table-td ">Methods and compositions for detecting BK virus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20110143349">US20110143349</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 12, 2011</td><td class="patent-data-table-td patent-date-value">Jun 16, 2011</td><td class="patent-data-table-td ">Focus Diagnostics, Inc.</td><td class="patent-data-table-td ">Methods and compositions for detecting bk virus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20120088681">US20120088681</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 4, 2011</td><td class="patent-data-table-td patent-date-value">Apr 12, 2012</td><td class="patent-data-table-td ">The Translational Genomics Research Institute</td><td class="patent-data-table-td ">Methods and kits used in classifying adrenocortical carcinoma</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE102008028357A1?cl=en">DE102008028357A1</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 2008</td><td class="patent-data-table-td patent-date-value">Feb 5, 2009</td><td class="patent-data-table-td ">Syngenta Participations Ag</td><td class="patent-data-table-td ">Neues Hybridsystem fÃ¼r Brassica napus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE102010049607A1?cl=en">DE102010049607A1</a></td><td class="patent-data-table-td patent-date-value">Oct 26, 2010</td><td class="patent-data-table-td patent-date-value">Jun 30, 2011</td><td class="patent-data-table-td ">Becker, Claus, Prof., 76470</td><td class="patent-data-table-td ">Konjugate von Nukleotiden und Methoden zu deren Anwendung</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE102012008375A1?cl=en">DE102012008375A1</a></td><td class="patent-data-table-td patent-date-value">Apr 26, 2012</td><td class="patent-data-table-td patent-date-value">Oct 31, 2012</td><td class="patent-data-table-td ">Genovoxx Gmbh</td><td class="patent-data-table-td ">Methoden und Komponenten zur Detektion von NukleinsÃ¤ureketten</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1185695A1?cl=en">EP1185695A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 12, 2000</td><td class="patent-data-table-td patent-date-value">Mar 13, 2002</td><td class="patent-data-table-td ">University Of Southern California</td><td class="patent-data-table-td ">Process for high throughput dna methylation analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1413630A1?cl=en">EP1413630A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td patent-date-value">Apr 28, 2004</td><td class="patent-data-table-td ">Commissariat A L&#39;energie Atomique</td><td class="patent-data-table-td ">Analyssis of biological targets using a biochip comprising a fluorescent marker</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1710321A2?cl=en">EP1710321A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 12, 2000</td><td class="patent-data-table-td patent-date-value">Oct 11, 2006</td><td class="patent-data-table-td ">University Of Southern California</td><td class="patent-data-table-td ">Process for high throughput DNA methylation analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2002711A1?cl=en">EP2002711A1</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 2008</td><td class="patent-data-table-td patent-date-value">Dec 17, 2008</td><td class="patent-data-table-td ">Syngeta Participations AG</td><td class="patent-data-table-td ">New hybrid system for brassica napus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2051077A2?cl=en">EP2051077A2</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 2004</td><td class="patent-data-table-td patent-date-value">Apr 22, 2009</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2107482A2?cl=en">EP2107482A2</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 2004</td><td class="patent-data-table-td patent-date-value">Oct 7, 2009</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Method and system for analyzing reactions using an information system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2112229A2?cl=en">EP2112229A2</a></td><td class="patent-data-table-td patent-date-value">Nov 25, 2003</td><td class="patent-data-table-td patent-date-value">Oct 28, 2009</td><td class="patent-data-table-td ">Sequenom, Inc.</td><td class="patent-data-table-td ">Methods for identifying risk of breast cancer and treatments thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2143796A2?cl=en">EP2143796A2</a></td><td class="patent-data-table-td patent-date-value">Feb 28, 2001</td><td class="patent-data-table-td patent-date-value">Jan 13, 2010</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">1983, 52881, 2398, 45449, 50289, and 52872, G protein-coupled receptors and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2220930A2?cl=en">EP2220930A2</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 2008</td><td class="patent-data-table-td patent-date-value">Aug 25, 2010</td><td class="patent-data-table-td ">Syngenta Participations AG</td><td class="patent-data-table-td ">New hybrid system for brassica napus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2236623A1?cl=en">EP2236623A1</a></td><td class="patent-data-table-td patent-date-value">Jun 5, 2007</td><td class="patent-data-table-td patent-date-value">Oct 6, 2010</td><td class="patent-data-table-td ">Cancer Care Ontario</td><td class="patent-data-table-td ">Assessment of risk for colorectal cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2243834A1?cl=en">EP2243834A1</a></td><td class="patent-data-table-td patent-date-value">Mar 5, 2008</td><td class="patent-data-table-td patent-date-value">Oct 27, 2010</td><td class="patent-data-table-td ">Cancer Care Ontario</td><td class="patent-data-table-td ">Assessment of risk for colorectal cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2261667A2?cl=en">EP2261667A2</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 2004</td><td class="patent-data-table-td patent-date-value">Dec 15, 2010</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Nucleic acid molecules and proteins for the identification, assessment, prevention, and their therapy of ovarian cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2295606A1?cl=en">EP2295606A1</a></td><td class="patent-data-table-td patent-date-value">Nov 28, 2001</td><td class="patent-data-table-td patent-date-value">Mar 16, 2011</td><td class="patent-data-table-td ">Wyeth LLC</td><td class="patent-data-table-td ">Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2305836A1?cl=en">EP2305836A1</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2003</td><td class="patent-data-table-td patent-date-value">Apr 6, 2011</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311978A1?cl=en">EP2311978A1</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311979A1?cl=en">EP2311979A1</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2311980A1?cl=en">EP2311980A1</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2003</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2312317A2?cl=en">EP2312317A2</a></td><td class="patent-data-table-td patent-date-value">May 3, 2006</td><td class="patent-data-table-td patent-date-value">Apr 20, 2011</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Fluorescent detection system and dye set for use therewith</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2314716A1?cl=en">EP2314716A1</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2003</td><td class="patent-data-table-td patent-date-value">Apr 27, 2011</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2316976A1?cl=en">EP2316976A1</a></td><td class="patent-data-table-td patent-date-value">Nov 28, 2001</td><td class="patent-data-table-td patent-date-value">May 4, 2011</td><td class="patent-data-table-td ">Wyeth LLC</td><td class="patent-data-table-td ">Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2436393A1?cl=en">EP2436393A1</a></td><td class="patent-data-table-td patent-date-value">Dec 19, 2002</td><td class="patent-data-table-td patent-date-value">Apr 4, 2012</td><td class="patent-data-table-td ">Millennium Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2442108A1?cl=en">EP2442108A1</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">Apr 18, 2012</td><td class="patent-data-table-td ">The Regents of the University of California</td><td class="patent-data-table-td ">Cancer biomarkers and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2442109A1?cl=en">EP2442109A1</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">Apr 18, 2012</td><td class="patent-data-table-td ">The Regents of the University of California</td><td class="patent-data-table-td ">Cancer biomarkers and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2450710A2?cl=en">EP2450710A2</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2007</td><td class="patent-data-table-td patent-date-value">May 9, 2012</td><td class="patent-data-table-td ">The Regents of the University of California</td><td class="patent-data-table-td ">Cancer biomarkers and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2476763A2?cl=en">EP2476763A2</a></td><td class="patent-data-table-td patent-date-value">Aug 29, 2008</td><td class="patent-data-table-td patent-date-value">Jul 18, 2012</td><td class="patent-data-table-td ">Monsanto Technology LLC</td><td class="patent-data-table-td ">Methods and compositions for breeding for preferred traits</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2662456A1?cl=en">EP2662456A1</a></td><td class="patent-data-table-td patent-date-value">Jul 25, 2006</td><td class="patent-data-table-td patent-date-value">Nov 13, 2013</td><td class="patent-data-table-td ">Focus Diagnostics, Inc.</td><td class="patent-data-table-td ">Methods and compositions for detecting BK virus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2730662A1?cl=en">EP2730662A1</a></td><td class="patent-data-table-td patent-date-value">Nov 12, 2009</td><td class="patent-data-table-td patent-date-value">May 14, 2014</td><td class="patent-data-table-td ">Caris Life Sciences Luxembourg Holdings</td><td class="patent-data-table-td ">Methods and systems of using exosomes for determining phenotypes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2740350A2?cl=en">EP2740350A2</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 2013</td><td class="patent-data-table-td patent-date-value">Jun 11, 2014</td><td class="patent-data-table-td ">Seminis Vegetable Seeds, Inc.</td><td class="patent-data-table-td ">Methods and compositions for watermelon sex expression</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001013086A2?cl=en">WO2001013086A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 14, 2000</td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td ">Univ Brandeis</td><td class="patent-data-table-td ">Detection of nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001063282A2?cl=en">WO2001063282A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 22, 2001</td><td class="patent-data-table-td patent-date-value">Aug 30, 2001</td><td class="patent-data-table-td ">Commissariat Energie Atomique</td><td class="patent-data-table-td ">Analysis of biological targets using a biochip comprising a fluorescent marker</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002021098A2?cl=en">WO2002021098A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 4, 2001</td><td class="patent-data-table-td patent-date-value">Mar 14, 2002</td><td class="patent-data-table-td ">Variagenics Inc</td><td class="patent-data-table-td ">A method for identifying polymorphisms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002072885A1?cl=en">WO2002072885A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 7, 2002</td><td class="patent-data-table-td patent-date-value">Sep 19, 2002</td><td class="patent-data-table-td ">Peter Estibeiro</td><td class="patent-data-table-td ">Detecting interactions between oligonucleotides and rna using fluorescence resonance energy transfer (fret)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003019138A2?cl=en">WO2003019138A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 23, 2002</td><td class="patent-data-table-td patent-date-value">Mar 6, 2003</td><td class="patent-data-table-td ">Qtl Biosystems Llc</td><td class="patent-data-table-td ">Bio-sensing platforms for detection and quantitation of biological molecules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2004018999A2?cl=en">WO2004018999A2</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2003</td><td class="patent-data-table-td patent-date-value">Mar 4, 2004</td><td class="patent-data-table-td ">Yan Chen</td><td class="patent-data-table-td ">Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2004053143A2?cl=en">WO2004053143A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 8, 2003</td><td class="patent-data-table-td patent-date-value">Jun 24, 2004</td><td class="patent-data-table-td ">Wanli Bi</td><td class="patent-data-table-td ">Concurrent enzymatic polynucleotide synthesis and detectable signal generation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2005043127A2?cl=en">WO2005043127A2</a></td><td class="patent-data-table-td patent-date-value">Oct 27, 2004</td><td class="patent-data-table-td patent-date-value">May 12, 2005</td><td class="patent-data-table-td ">Epoch Biosciences Inc</td><td class="patent-data-table-td ">Fluorescent probes for dna detection by hybridization with improved sensitivity and low background</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006045009A2?cl=en">WO2006045009A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 20, 2005</td><td class="patent-data-table-td patent-date-value">Apr 27, 2006</td><td class="patent-data-table-td ">Andrew Firmin</td><td class="patent-data-table-td ">Triplex probe compositions and methods for polynucleotide detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009132089A2?cl=en">WO2009132089A2</a></td><td class="patent-data-table-td patent-date-value">Apr 22, 2009</td><td class="patent-data-table-td patent-date-value">Oct 29, 2009</td><td class="patent-data-table-td ">Monsanto Technology Llc</td><td class="patent-data-table-td ">A method to identify asian soybean rust resistance quantitative trait loci in soybean and compositions thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011050938A1?cl=en">WO2011050938A1</a></td><td class="patent-data-table-td patent-date-value">Oct 26, 2010</td><td class="patent-data-table-td patent-date-value">May 5, 2011</td><td class="patent-data-table-td ">Genovoxx Gmbh</td><td class="patent-data-table-td ">Conjugates of nucleotides and method for the application thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011069676A2?cl=en">WO2011069676A2</a></td><td class="patent-data-table-td patent-date-value">Dec 10, 2010</td><td class="patent-data-table-td patent-date-value">Jun 16, 2011</td><td class="patent-data-table-td ">Roche Diagnostics Gmbh</td><td class="patent-data-table-td ">Preferential amplification of mrna over dna using chemically modified primers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011139721A1?cl=en">WO2011139721A1</a></td><td class="patent-data-table-td patent-date-value">Apr 26, 2011</td><td class="patent-data-table-td patent-date-value">Nov 10, 2011</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Cancer biomarkers and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011150277A2?cl=en">WO2011150277A2</a></td><td class="patent-data-table-td patent-date-value">May 26, 2011</td><td class="patent-data-table-td patent-date-value">Dec 1, 2011</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Synthesis of 2&#39;, 3&#39;-dideoxynucleosides for automated dna synthesis and pyrophosphorolysis activated polymerization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012042516A2?cl=en">WO2012042516A2</a></td><td class="patent-data-table-td patent-date-value">Sep 25, 2011</td><td class="patent-data-table-td patent-date-value">Apr 5, 2012</td><td class="patent-data-table-td ">Mor Research Applications Ltd.</td><td class="patent-data-table-td ">Prognostic methods, compositions and kits for prediction of acute lymphoblastic leukemia (all) relapse</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012073053A1?cl=en">WO2012073053A1</a></td><td class="patent-data-table-td patent-date-value">Nov 30, 2010</td><td class="patent-data-table-td patent-date-value">Jun 7, 2012</td><td class="patent-data-table-td ">Diagon Kft.</td><td class="patent-data-table-td ">Procedure for nucleic acid-based molecular diagnostic determination of bacterial germ counts and kit for this purpose</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012099896A2?cl=en">WO2012099896A2</a></td><td class="patent-data-table-td patent-date-value">Jan 17, 2012</td><td class="patent-data-table-td patent-date-value">Jul 26, 2012</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Workflow for detection of ligands using nucleic acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012139058A1?cl=en">WO2012139058A1</a></td><td class="patent-data-table-td patent-date-value">Apr 6, 2012</td><td class="patent-data-table-td patent-date-value">Oct 11, 2012</td><td class="patent-data-table-td ">Biogen Idec Ma Inc.</td><td class="patent-data-table-td ">BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNÎ² AND USES THEREOF</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012149193A2?cl=en">WO2012149193A2</a></td><td class="patent-data-table-td patent-date-value">Apr 26, 2012</td><td class="patent-data-table-td patent-date-value">Nov 1, 2012</td><td class="patent-data-table-td ">Monsanto Technology Llc</td><td class="patent-data-table-td ">Diagnostic molecular markers for seed lot purity traits in soybeans</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012170907A2?cl=en">WO2012170907A2</a></td><td class="patent-data-table-td patent-date-value">Jun 8, 2012</td><td class="patent-data-table-td patent-date-value">Dec 13, 2012</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Polymerization of nucleic acids using proteins having low isoelectric points</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012170908A1?cl=en">WO2012170908A1</a></td><td class="patent-data-table-td patent-date-value">Jun 8, 2012</td><td class="patent-data-table-td patent-date-value">Dec 13, 2012</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Design and development of novel detergents for use in pcr systems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013030841A1?cl=en">WO2013030841A1</a></td><td class="patent-data-table-td patent-date-value">Sep 3, 2012</td><td class="patent-data-table-td patent-date-value">Mar 7, 2013</td><td class="patent-data-table-td ">Yissum Research Development Company Of The Hebrew Universitiy Of Jerusalem Ltd.</td><td class="patent-data-table-td ">Prognostic methods and compositions for predicting interferon treatment eficacy in a subject</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013168162A1?cl=en">WO2013168162A1</a></td><td class="patent-data-table-td patent-date-value">May 9, 2013</td><td class="patent-data-table-td patent-date-value">Nov 14, 2013</td><td class="patent-data-table-td ">Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.</td><td class="patent-data-table-td ">Clustered single nucleotide polymorphisms in the human acetylcholinesterase gene and uses thereof in diagnosis and therapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013188839A1?cl=en">WO2013188839A1</a></td><td class="patent-data-table-td patent-date-value">Jun 14, 2013</td><td class="patent-data-table-td patent-date-value">Dec 19, 2013</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Novel compositions, methods and kits for real time polymerase chain reaction (pcr)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014071315A1?cl=en">WO2014071315A1</a></td><td class="patent-data-table-td patent-date-value">Nov 4, 2013</td><td class="patent-data-table-td patent-date-value">May 8, 2014</td><td class="patent-data-table-td ">Life Technologies Corporation</td><td class="patent-data-table-td ">Novel compositions, methods and kits for enhancing pcr specificity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014071358A2?cl=en">WO2014071358A2</a></td><td class="patent-data-table-td patent-date-value">Nov 5, 2013</td><td class="patent-data-table-td patent-date-value">May 8, 2014</td><td class="patent-data-table-td ">Foundation Medicine, Inc.</td><td class="patent-data-table-td ">Novel ntrk1 fusion molecules and uses thereof</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S006110">435/6.11</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024300">536/24.3</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S091200">435/91.2</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024330">536/24.33</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S005000">435/5</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S091100">435/91.1</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S025320">536/25.32</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S026600">536/26.6</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S025300">536/25.3</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc536/defs536.htm&usg=AFQjCNHex3TR9tihVxBKQnsQg6n8YmdVYg#C536S024320">536/24.32</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S006100">435/6.1</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07H0021000000">C07H21/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12Q0001680000">C12Q1/68</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0015090000">C12N15/09</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0015000000">C12N15/00</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12Q1/6837">C12Q1/6837</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12Q1/6834">C12Q1/6834</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=5dRJBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12Q1/6818">C12Q1/6818</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">C12Q1/68B2B</span>, <span class="nested-value">C12Q1/68B10</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Oct 29, 2013</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 3-5 AND 20-22 ARE CANCELLED.CLAIMS 1, 6, 16, 18, 23 AND 38 ARE DETERMINED TO BE PATENTABLE AS AMENDED.CLAIMS 2, 7-15, 17, 19, 24-37 AND 39, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 9, 2013</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS, INC., CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20100528</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">LIEN RELEASE;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:030182/0677</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 17, 2012</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120530</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 2, 2010</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 26, 2010</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:23994/538</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS INC.,CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20080701</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS, LLC,CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:23985/801</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:23994/587</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20081121</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:023985/0801</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:023994/0538</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:023994/0587</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS, LLC, CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS INC., CALIFORNIA</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 20, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS INC., CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:ATOM ACQUISITION CORPORATION;REEL/FRAME:022973/0320</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLIED BIOSYSTEMS, LLC, CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:ATOM ACQUISITION, LLC AND APPLIED BIOSYSTEMS INC.;REEL/FRAME:022973/0327</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20081121</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:022973/0313</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20080630</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 5, 2008</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BANK OF AMERICA, N.A, AS COLLATERAL AGENT, WASHING</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">SECURITY AGREEMENT;ASSIGNOR:APPLIED BIOSYSTEMS, LLC;REEL/FRAME:021976/0001</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20081121</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BANK OF AMERICA, N.A, AS COLLATERAL AGENT,WASHINGT</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">SECURITY AGREEMENT;ASSIGNOR:APPLIED BIOSYSTEMS, LLC;REEL/FRAME:21976/1</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 5, 2006</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 31, 2005</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLERA CORPORATION, CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FLOOD, SUSAN J. A.;REEL/FRAME:015621/0426</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20050128</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLERA CORPORATION 850 LINCOLN CENTRE DRIVE APPLI</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FLOOD, SUSAN J. A. /AR;REEL/FRAME:015621/0426</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 17, 2004</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLERA CORPORATION, CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIVAK, KENNETH J.;MARMARO, JEFFREY;MULLAH, KHAIRUZZAMAN BASHAR;REEL/FRAME:015469/0076;SIGNING DATES FROM 20041015 TO 20041027</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">APPLERA CORPORATION 850 LINCOLN CENTRE DRIVE APPLI</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIVAK, KENNETH J. /AR;REEL/FRAME:015469/0076;SIGNING DATES FROM 20041015 TO 20041027</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 17, 2002</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 30, 2002</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 30, 2002</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 25, 1996</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">PERKIN-ELMER CORPORATION, CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIVAK, KENNETH J.;FLOOD, SUSAN J.A.;MARMARO, JEFFREY;ANDOTHERS;REEL/FRAME:007870/0145;SIGNING DATES FROM 19960307 TO 19960314</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_4ff636b3d23669b7103f3b3a3a18b4cd.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U3PaPYUM6449gN9NCNISwajfAp9lA\u0026id=5dRJBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U0_DEf6mOHjb9yhDruAUaN7a_hupQ\u0026id=5dRJBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U26CRyPdpn_VN3iazIXtaDpdHE8dA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Detecting_polynucleotide_in_sample_using.pdf?id=5dRJBAABERAJ\u0026output=pdf\u0026sig=ACfU3U0qQEcK0MjEH1e4jhssEJ3qi8VdIA"},"sample_url":"http://www.google.com/patents/reader?id=5dRJBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>